Patent Application
20190184364
Consumers prefer long-lasting fragrances. In consumer products such as detergents and hair conditioners, microcapsules have been used to delay the release, increase fragrance intensity, and deliver fragrance at a moment when needed.
However, when suspended in a fine fragrance composition such as an Eau de Toilette (EDT) and Eau de Parfum (EDP), microcapsules tend to precipitate from the fragrance solution and also make it cloudy. The high level of ethanol in the fine fragrance solution also makes microcapsules unstable and releasing fragrances prematurely. Preparation of stable and clear microcapsule suspension remains a challenge in fine fragrances.
To avoid premature release of encapsulated fragrance in a fine fragrance solution, US20150352575A1 devised a dispenser having two compartments to separately apply a microcapsule slurry devoid of ethanol and a fine fragrance with a high content of ethanol. Particles have been added to fragrance solutions to impart color or light reflection, but not for controlled release of the fragrance. See U.S. Pat. No. 9,102,898B2. Absorbing microcapsules are used to encapsulate fragrances with ingredients having either high water solubility or high reactivity towards wall materials. See US20180064615A1. Such capsules when suspended in EDT solutions were found not stable enough during shelf storage.
Silica microcapsules have been used to encapsulate fragrances. See U.S. Pat. Nos. 9,044,732, 9,532,933, and US20140044761. They have not been used in fragrance solutions having a high level of ethanol due the fragile nature of the silica microcapsule wall. That is possible the reason that no commercially product has been found for alcohol-based fragrance solutions containing silica microcapsules.
Thus there is a need to develop a fragrance solution that has improved stability, manufacturability and product aesthetics.
This invention is based on the unexpected discovery of stable fine fragrance solutions containing a microcapsule for extended release of fragrance and a high level of ethanol as a solvent.
Accordingly, one aspect of this invention relates to a fragrance composition comprising:
(1) a microcapsule having a particle size of 1 micron to 100 microns,
(2) a fragrance,
(3) a hydrocolloid selected from the group consisting of a copolymer of acrylate and C10-C30 alkyl acrylate, a copolymer of acrylic acid and vinyl pyrrolidone, a copolymer of acrylic acid and C10-C30 alkyl acrylate, a homopolymer of acrylic acid, or a combination thereof, and
(4) a solvent.
In the fragrance composition, the microcapsule is homogeneously suspended in the solvent and has a microcapsule core and a microcapsule wall encapsulating the microcapsule core, and the microcapsule wall is formed of an encapsulating polymer.
Typically, the fragrance composition also contains a neutralizing agent at a level of 0.1% to 4% (e.g., 0.1% to 3%, 0.2% to 2%, and 0.2% to 1%). Exemplary neutralizing agents include triethylamine, 2-amino-2-methyl-1-propanol (AMP, commercially available from Dow Chemical, Midland, Mich.), Triisopropanolamine (TIPA, commercially available from Dow Chemical), tetrahydroxypropyl ethylene diamine (commercially available under the trademark of Neutrol® TE from BASF, Florham Park, N.J.), polyoxyethylene (15) cocoalkylamine (commercially available under the trademark of Ethomeen® C/25 from Nouryon, Bridgewater, N.J.), bis(2-hydroxylethyl)soyaalkylamine (commercially available under the trademark of Ethomeen® SV/12 from Nouryon), octadecyl dimethyl amine (commercially available under the trademark of Armeen® DM18D from Nouryon), polyethylene glycol-based amines, poly(diallyldimethylammonium chloride) (PQ-6), and copolymer of vinylpyrrolidone and quaternized dimethylaminoethyl methacrylate (PQ-11).
In some embodiments, the fragrance is present at a level of 0.1% to 30% (e.g., 0.1% to 25%, 0.1% to 20%, 2% to 18%, and 5% to 15%). The fragrance can be a free fragrance oil, namely, an unencapsulated fragrance. It can also be encapsulated in a microcapsule. In some embodiments, the fragrance composition contains 1% to 10% of a free first fragrance, and 1% to 10% of an encapsulated second fragrance. The first and second fragrance can be the same or different.
The fragrance compositions of this invention contain a solvent, typically a mixture of (i) water present at a level of 0% to 30% (e.g., 0.01% to 30%, 0.05% to 20%, 0.1% to 10%, and 0.1% to 5%) by weight of the composition and (ii) ethanol present at a level of 50% to 95% (e.g., 55% to 95%, 50% to 90%, 60% to 90%, 60% to 85%, 65% to 80%, and 70% to 80%), also by weight of the composition.
The fragrance compositions of this invention further contain a microcapsule at a level of 0.5% to 10% (e.g., 0.5% to 8%, 0.5% to 7%, and 0.5% to 5%). The preferred microcapsule is a core-shell type microcapsule having a single microcapsule core encapsulated by a microcapsule wall that is formed of an encapsulating polymer. Examples of the encapsulating polymer include polyacrylate, polyurea, polyurethane, polyacrylamide, polyester, polyether, polyamide, poly(acrylate-co-acrylamide), starch, silica, gelatin and gum Arabic, alginate, chitosan, polylactide, poly(melamine-formaldehyde), poly(urea-formaldehyde), and combinations thereof. Preferably, the encapsulating polymer is polyurea, silica, poly(urea-formaldehyde).
The fragrance compositions of this invention also contain 0.1% to 5% (0.3% to 5%, 0.1% to 3% 0.2% to 2%, and 0.3% to 1.2%) of a structural agent. Preferably the structural agent is a hydrocolloid or rheology modifier. Optionally, the fragrance compositions contain a surfactant at the level of 0.1% to 5% (e.g., 0.1% to 1%, and 0.1% to 0.5%). Preferably, the fragrance compositions have a pH of 2 to 9 (e.g., 3 to 8, 5 to 8, and 6 to 7.7).
It is desirable that the fragrance composition is transparent, having a visible light transmittance of 80% or greater (e.g., 90% or greater and 95% or greater). The visible light transmittance can be measured in the wavelength range between 400 nm and 800 nm with a visible light transmission meter. In addition, the clarity of the fragrance composition can be defined using the CIE L*a*b* color values, where L is the lightness with a fully clear EDT having an L=99-100 (a score of 99 or grater means fully transparent) and a*, b* values depending on the color of the fragrance used. The a* axis represents the green-red component, with green in the negative direction and red in the positive direction. The b* axis represents the blue-yellow component, with blue in the negative direction and yellow in the positive direction.
The details of one or more embodiments of the invention are set forth in the description below. Other features, objects, and advantages will be apparent from the description and the claims.
Reloadable microcapsules (namely, absorbing microcapsules) useful for this invention can be prepared in absence of an active material (e.g., fragrance), thus avoiding the reaction between the active material and a wall-forming material. This reloadable microcapsule unexpectedly improves substantivity of a free fragrance on fabric or skin. It provides a facile method for delivering active materials in consumer products.
Reloadable microcapsules each have a microcapsule core and a microcapsule wall. The microcapsule core is encapsulated in the microcapsule wall and contains a hydrophilic core solvent and/or a hydrophobic core solvent. The microcapsule wall, formed of an encapsulating polymer, is permeable to the hydrophilic core solvent and the active material.
The microcapsule core typically contains by weight of the core 1% to 99% of the hydrophilic solvent and 1% to 99% of the hydrophobic solvent, preferably 10% to 90% of the hydrophilic solvent and 10% to 90% of the hydrophobic solvent, more preferably 25% to 75% of the hydrophilic solvent and 25% to 75% of the hydrophobic solvent, and most preferably 40% to 60% of the hydrophilic solvent and 40% and 60% of the hydrophobic solvent.
In some embodiments, the microcapsule core, free of an active material (e.g., a fragrance), consists of a hydrophobic core solvent and a hydrophilic core solvent. Namely, the amount of the hydrophilic solvent and the hydrophobic solvent is 100% by weight of the microcapsule core. The hydrophilic core solvent has a water solubility of 1 g/L to 100 g/L, a weighted Hansen solubility parameter of 18 or greater, a Hansen polarizability of 4 or greater, and a Hansen h-bonding value of 5 or greater; and the hydrophobic core solvent has a weighted Hansen solubility parameter of 18 or less, a Hansen polarizability of 4 or less, and a Hansen h-bonding value of 5 or less. The weight ratio between the hydrophobic core solvent and the hydrophilic core solvent can be in the range of 1:9 to 9:1.
Examples of the hydrophilic core solvent include, but are not limited to, triethyl citrate, triacetin, benzyl acetate, ethyl acetate, propylene glycol, dipropylene glycol, glycol ethers, and combinations thereof. Exemplary hydrophobic core solvents are isopropyl myristate, C5-050 (e.g., C5-C20 and C6-C15) tryglyceride (e.g., caprylic triglyceride, capric triglyceride, and a mixture thereof), D-limonene, silicone oil, mineral oil, and combinations thereof. In some embodiments, the hydrophobic core solvent contains a fragrance ingredient having a ClogP of 2 or greater (e.g., 2.5 or greater, 3 or greater, 3.3. or greater). In other embodiments, the hydrophobic core solvent is free of any fragrance ingredient. The term “fragrance ingredient” refers to materials which may be acceptably employed within fragrances to provide a contribution of an odor, fragrance, essence, or scent either alone or in combination with other fragrance ingredients. Typically, such materials will be relatively volatile, and characterized by molecular weights within the range of at least 100 g/mol.
In other embodiments, the microcapsule has a size of 0.1 μm to 1000 μm in diameter. The weight ratio between the microcapsule core and the microcapsule wall is preferably in the range of 1:99 to 99:1 (e.g., 1:1 to 50:1, 5:1 to 50:1, and 5:1 to 20:1). Suitable encapsulating polymers for the microcapsule wall include polyacrylate, polyurea, polyurethane, polyacrylamide, polyester, polyether, polyamide, poly(acrylate-co-acrylamide), starch, silica, gelatin and gum Arabic, alginate, chitosan, polylactide, poly(melamine-formaldehyde), poly(urea-formaldehyde), and combinations thereof.
One aspect of this invention relates to microcapsule compositions (including fine fragrance compositions) containing any of the microcapsules described above and a continuous phase that has an external hydrophilic or ethanolic solvent and an active material, in which the microcapsule wall is permeable to the active material, the ratio between the microcapsule core and the active material is 1:99 to 99:1, and the active material is selected from the group consisting of a fragrance, pro-fragrance, flavor, malodor counteractive agent, vitamin or derivative thereof, anti-inflammatory agent, fungicide, anesthetic, analgesic, antimicrobial active, anti-viral agent, anti-infectious agent, anti-acne agent, skin lightening agent, insect repellent, animal repellent, vermin repellent, emollient, skin moisturizing agent, wrinkle control agent, UV protection agent, fabric softener active, hard surface cleaning active, skin or hair conditioning agent, flame retardant, antistatic agent, taste modulator, cell, probiotic, antioxidant, self-tanning agent, dihydroxyacetone, cooler, sensate, malodor reactive material, cosmetic active, and combinations thereof. The active material is initially outside of the microcapsule wall.
Nonlimiting exemplary external hydrophilic or ethanolic solvents are water, ethanol, propanol, dipropylene glycol, propylene glycol, glycerin, diethyl phthalate, and combinations thereof.
In some microcapsule compositions, the active material is a fragrance having a weighted Hansen solubility parameter of 15 to 20, a Hansen polarizability of 5 or less, and a Hansen h-bonding value of 10 or less. In other microcapsule compositions, the fragrance contains two or more fragrance ingredients, 50 wt % or more of the fragrance ingredients have a water solubility of 0.1 g/L or less, 50 wt % or less of the fragrance ingredients have a vapor concentration of 100 μg/L or less, and 30 wt % or less of the fragrance ingredients have a CLogP of 3 or less. In still other microcapsule compositions, the Euclidean difference in solubility parameter between the fragrance and the hydrophilic core solvent is less than the Euclidean difference between the fragrance and the hydrophobic core solvent. In yet other microcapsule compositions, the Euclidean difference in solubility parameter between the fragrance and the hydrophobic core solvent is less than 5.
Any of the microcapsule compositions described above can further contain a deposition aid such as polyquaternium-4, polyquaternium-5, polyquaternium-6, polyquaternium-7, polyquaternium-10, polyquaternium-16, polyquaternium-22, polyquaternium-24, polyquaternium-28, polyquaternium-39, polyquaternium-44, polyquaternium-46, polyquaternium-47, polyquaternium-53, polyquaternium-55, polyquaternium-67, polyquaternium-68, polyquaternium-69, polyquaternium-73, polyquaternium-74, polyquaternium-77, polyquaternium-78, polyquaternium-79, polyquaternium-80, polyquaternium-81, polyquaternium-82, polyquaternium-86, polyquaternium-88, polyquaternium-101, polyvinylamine, polyethyleneimine, polyvinylamine and vinylformamide copolymer, polymer comprising units derived from polyethylene glycol and terephthalate, and any combination thereof.
Also within the scope of this invention is a method of preparing a microcapsule composition such as a fine fragrance composition containing a microcapsule. The method includes: (a) providing a microcapsule that has a microcapsule core and a microcapsule wall encapsulating the microcapsule core, in which the microcapsule core contains a hydrophilic core solvent and/or a hydrophobic core solvent, and the microcapsule wall is formed of an encapsulating polymer and permeable to the hydrophilic core solvent; (b) providing a continuous phase that has an external hydrophilic solvent and an active material; (c) mixing the microcapsule and the continuous phase to obtain a microcapsule dispersion; and (d) aging the microcapsule dispersion to obtain the microcapsule composition.
Still within the scope of this invention are consumer products containing any one of the microcapsule compositions described above. The consumer product can be liquid or semisolid products such as a baby care product, a diaper rash cream or balm, a baby powder, a diaper, a bib, a baby wipe, a cosmetic preparation, a powder foundation, a liquid foundation, an eye shadow, a lipstick or lip balm, a home care product, an all-purpose cleaner, a bathroom cleaner, a floor cleaner, a window cleaner, a plastics polish, a bleach, a toilet cleaner, a toilet rimblock, a bath tissue, a paper towel, a disposable wipe, liquid air freshener, air freshener spray, a spray dispenser product, an incense stick, a rug deodorizer, a candle, a room deodorizer, a liquid dish detergent, an automatic dish detergent, a powder dish detergent, a leather detergent, a tablet dish detergent, a paste dish detergent, a unit dose tablet or capsule, a flavor, a beverage flavor, a diary flavor, a fruit flavor, a miscellaneous flavor, a sweet goods flavor, a tobacco flavor, a toothpaste flavor, a chewing gum, a breath freshener, an orally dissolvable strips, a chewable candy, a hard candy, an oral care product, a tooth paste, a toothbrush, a dental floss, an oral rinse, an tooth whitener, a denture adhesive, a health care device, a tampon, a feminine napkin, an anti-inflammatory balm, an anti-inflammatory ointment, an anti-inflammatory spray, a disinfectant, a personal care product, a soap, a bar soap, a liquid soap, a bath fragrance, a body wash, a non-aerosol body spray, a body milk, a cleanser, a body cream, a hand sanitizer, a hand wash, a functional product base, a sunscreen lotion, a sunscreen spray, a deodorant, an anti-perspirant, an roll-on product, an aerosol product, a natural spray product, a wax-based deodorant, a glycol type deodorant, a soap type deodorant, a facial lotion, a body lotion, a hand lotion, a miscellaneous lotion, a body powder, a shave cream, a shave gel, a shave butter, a bath soak, a shower gel, an exfoliating scrub, a foot cream, a facial tissue, a cleansing wipe, a talc product, a hair care product, a hair care with ammonia, a shampoo, a hair conditioner, a hair rinse, a hair refresher, a hair fixative or styling aid, a hair bleach, a hair dye or colorant, a fabric care product, a fabric softener, a liquid fabric softener, a fabric softener sheet, a drier sheet, a fabric refresher, an ironing water, a detergent, a laundry detergent, a liquid laundry detergent, a powder laundry detergent, a tablet laundry detergent, a laundry detergent bar, a laundry detergent cream, a hand wash laundry detergent, a scent booster, a fragrance, a cologne, compounds, an encapsulated fragrance, a fine fragrance, a men's fine fragrance, a women's fine fragrance, a perfume, a solid perfume, an Eau De Toilette product, a natural spray product, a perfume spray product, an insect repellent product, and a wildlife scent.
An exemplary consumer product is an aerosol product containing 0.01% to 50% of any one of the above-described microcapsule compositions.
Another example is a perfume spray product containing 0.01% to 40% of the microcapsule composition, 0.01% to 40% of a fragrance as the active material, at least 60% of ethyl alcohol, 0 to 30% of a suspending polymer, and 0 to 30% of an emollient. The suspending agent can be polyacrylate crosspolymer-6, acrylates/C10-C30 alkyl acrylate crosspolymer, or a combination thereof, and the emollient is trilsononanoin, ethylhexyl isononanoate, cyclopentasiloxane, or a combination thereof.
Still another example is an insect repellent containing (i) 2% to 95% (e.g., 2% to 40%, 2% to 20%, 2% to 10%, 4% to 35%, and 5% to 30%) of an insect repellent such as N,N-Diethyl-meta-toluamide (“DEET”) and (ii) 1% to 50% (e.g., 2% to 40%, 2% to 30%, 5% to 30%, and 5% to 20%) of the microcapsule composition. The insect repellent DEET is used in current consumer products in concentrations from 2% to 100% without microcapsules. A direct correlation is found between neat DEET concentration and hours of protection against insect bites. DEET at 100% was found to offer up to 12 hours of protection. At 20% to 34%, DEET offered 3 to 6 hours of protection. See Matsuda et al., Journal of the American Mosiquito Control Association (1996), 12, 69-74.
The insect repellent product of this invention typically contains DEET outside of the microcapsule core and (ii) of the microcapsule composition of this invention. The insect repellent products of this product offer not only higher repellent efficiency, but also longer effective time and greater storage stability as a result of the protection provided by the microcapsules. In the insect repellent compositions, the microcapsule has a microcapsule core containing 10% to 90% (e.g., 20% to 80% and 40% to 60%) of a hydrophilic solvent and 90% to 10% (e.g., 80% to 20% and 60% to 40%) of a hydrophobic solvent, by weight of the microcapsule core. After the formation of a microcapsule, DEET is added to the microcapsule and adsorbed onto the microcapsule. In some embodiments, the microcapsule core does not contain DEET. In other embodiments, the microcapsule core contains 1% to 30% (e.g., 2% to 20% and 5% to 15%) of DEET by weight of the microcapsule core.
In some embodiments, the insect repellent composition contains a continuous phase (water, an alcohol such as ethanol or isopropanol, or combination thereof). The microcapsule is dispersed in the continuous phase. The insect repellent (such as DEET) is dispersed or dissolved in the continuous phase and the concentration of DEET outside of the microcapsule core is 2% to 40% (e.g., 2% to 20%, 2% to 20%, 2% to 10%, and 4% to 20%).
Accordingly, one aspect of this invention relates to a method of preparing an insect repellent composition. The method comprises the step of: (a) providing a microcapsule comprising a microcapsule wall and a microcapsule core, the microcapsule wall is formed of an encapsulating polymer described above, and the microcapsule core contains 10% to 90% (e.g., 20% to 80% and 40% to 60%) of a hydrophilic solvent and 90% to 10% (e.g., 80% to 20% and 60% to 40%) of a hydrophobic solvent, by weight of the microcapsule core; and (b) adding an insect repellent active such as DEET to the microcapsule to obtain the insect repellent composition of this invention. Preferably, the amount of the hydrophilic solvent and the hydrophobic solvent is 100% by weight of the microcapsule core.
All parts, percentages and proportions refer to herein and in the claims are by weight unless otherwise indicated.
The values and dimensions disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such value is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a value disclosed as “50%” is intended to mean “about 50%.”
The terms “capsule” and “microcapsule” are used interchangeably.
The terms “g,” “mg,” and “μg” refer to “gram,” “milligram,” and “microgram,” respectively. The terms “L” and “mL” refer to “liter” and “milliliter,” respectively.
The term “Hansen solubility parameter” refers to a solubility parameter approach proposed by
Charles Hansen used to predict polymer solubility and was developed around the basis that the total energy of vaporization of a liquid consists of several individual parts. To calculate the “weighted Hansen solubility parameter” one must combine the effects of (atomic) dispersion forces, (molecular) permanent dipole-permanent dipole forces, and (molecular) hydrogen bonding (electron exchange). The weighted Hansen solubility parameter” is calculated as (δD2+δP2+δH2)0.5, wherein δD is the Hansen dispersion value, δP is the Hansen polarizability value, and δH is the Hansen Hydrogen-bonding (“h-bonding”) value. For a more detailed description of the parameters and values, see Charles Hansen, The Three Dimensional Solubility Parameter and Solvent Diffusion Coefficient, Danish Technical Press (Copenhagen, 1967).
Euclidean difference in solubility parameter between a fragrance and a solvent is calculated as (4*(δDsolvent−δDfragrance)2+(δPsolvent−δPfragrance)2+(δHsolvent−δHfragrance)2)0.5, in which δDsolvent, δPsolvent, and δHsolvent are the Hansen dispersion value, Hansen polarizability value, and Hansen h-bonding values of the solvent, respectively; and δDfragrance, δPfragrance, and δHfragrance are the Hansen dispersion value, Hansen polarizability value, and Hansen h-bonding values of the fragrance, respectively.
The reloadable microcapsules formulated with a hydrophilic solvent unexpectedly improved substantivity of an active material (e.g., fragrance) not initially encapsulated in the microcapsules.
The microcapsule wall of the reloadable microcapsule is permeable to both the hydrophilic core solvent and the active material (e.g., a fragrance). The microcapsule core encapsulated by the microcapsule wall and contains the hydrophilic core solvent alone or in combination with a hydrophobic core solvent. In a preferred embodiment, the microcapsule core consists of a hydrophilic solvent and a hydrophobic solvent and is free of an active material.
In some embodiments, the reloadable microcapsule is then formulated with an active material in an external hydrophilic solvent. The hydrophilic core solvent is believed to diffuse from the microcapsule core to the external hydrophilic solvent and create a void in the microcapsule core. The active material diffuses in an opposite direction, i.e., from the external hydrophilic solvent to the void in the microcapsule core, thus affording a microcapsule composition without the need to encapsulating the active material during the preparation of the reloadable microcapsule.
Such a microcapsule composition is shown to be an effective delivery system capable of delivering a fragrance with enhanced longevity in an alcohol based carrier. By preparing a reloadable microcapsule without a fragrance, the delivery system can later incorporate a fragrance of choice into the reloadable microcapsule for a specific application. Thus, significant economies of scale and enhancements of creative flexibility can be achieved.
The microcapsule composition can assist the delivery of fragrance components with low substantivity, thereby expanding the fragrance pallet. The term substantivity refers to the property of the encapsulated fragrance to be retained on a solid surface (such as skin, hair, laundry, furniture, and floor) for a prolonged period of time.
The microcapsule composition also allows for the delivery of fragrance components with functional groups such as aldehydes and primary alcohols, which would otherwise react with capsule wall materials. These functional groups are indeed common in fragrances as well as other active materials.
Further, the microcapsule composition also has applicability in applications such as skin care products where topical substantivity of a hydrophobic semi-volatile skin care active is needed. Some non-limiting examples include sunscreens, topical analgesics, antibacterial agents, and combinations thereof.
Also envisioned is the ability of the microcapsule composition to enhance substantivity and release of a semi-volatile active in other applications such as cosmetics, pesticides, insect repellents, herbicides, and pheromone baits for pest control.
The microcapsule composition delivery system also find its utility in a wide range of consumer applications, e.g., personal care products including shampoos, hair conditioners, hair rinses, hair refreshers; personal wash such as bar soaps, body wash, personal cleaners and sanitizers; fabric care such as fabric refreshers, softeners and dryer sheets, ironing water, industrial cleaners, liquid and powder detergent including unit dose capsules, rinse conditioners, and scent booster products; fine fragrances such as body mist and Eau De Toilette products; deodorants; roll-on products, and aerosol products. A specific consumer product is an alcohol deodorant spray product.
Not to be bound by any theory, it is believed that, when mixing a reloadable microcapsule with an active material in an external hydrophilic solvent, the hydrophilic core solvent diffuses from the core to the external hydrophilic solvent, making space for the active material to diffuse from the external hydrophilic solvent to the microcapsule core until the equilibrium is reached.
The microcapsule wall has pores or channels making the wall permeable to both the hydrophilic core solvent and the active material. Permeability also relates to the thickness of the wall, which can be controlled or manipulated by the weight ratio between the microcapsule core and the microcapsule wall forming materials. This weight ratio can be 100:1 to 1:1 (e.g., 50:1 to 5:1 and 40:1 to 8:1). By using a higher ratio (namely more microcapsule core than microcapsule wall-forming materials), the microcapsule wall becomes thinner and is more permeable.
The microcapsule wall is formed of an encapsulating polymer that can be polyurea, polyurethane, alginate, gelatin, urea formaldehyde, melamine formaldehyde, acrylate hydrogel, polylactide, chitosan, silica, or a combination thereof.
Turning to the microcapsule core, it contains a hydrophilic core solvent. The water solubility of this solvent can be 0.02 g/L to 300 g/L (e.g, 0.1 g/L to 200 g/L and 1 g/L to 100 g/L). The hydrophilic core solvent typically has a weighted Hansen solubility parameter of 18 or greater, a Hansen polarizability (HP) of 4 or greater, and a Hansen h-bonding value (δH) of 5 or greater.
Preferably, the hydrophilic core solvent has a vapor concentration at 25° C. of 4.6 μg/L or greater. The vapor concentration of a solvent refers to the mass of the solvent vapor present per unit volume of air expressed in micrograms per liter (μg/L) at a standard atmosphere (atm). The vapor concentrations of various solvent are available from reference materials such as the CRC Handbook of Chemistry and Physics, 98th Edition (CRC Press 2017). The vapor concentration can be determined by ASTM D323 or ASTM D4953.
Exemplary hydrophilic core solvents are triethyl citrate, triacetin, benzyl acetate, ethyl acetate, propylene glycol, dipropylene glycol, and combinations thereof. More examples include glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, ethylene glycol monophenyl ether, ethylene glycol monobenzyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono-n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, and combinations thereof.
Besides the hydrophilic core solvent, the microcapsule core can also contain a hydrophobic core solvent having a weighted Hansen solubility parameter of 18 or less, a Hansen polarizability (HP) value of 4 or less, and a Hansen h-bonding value (δH) of 5 or less. Preferably, the hydrophobic core solvent has a vapor concentration at 25° C. of 0.1 μg/L or less.
These hydrophobic solvents, being nonvolatile (i.e., having a boiling point of 100° C. or higher), are added to modify the hydrophilicity/hydrophobicity of the microcapsule core solvents for optimized fragrance diffusion. In some embodiments, hydrophobic solvents are used to increase the compatibility of various active materials, increase the overall hydrophobicity of the core solvents, influence the vapor pressure, or serve to structure the mixture. Suitable solvents include those having reasonable affinity for the active materials and a ClogP greater than 2.5, preferably greater than 3.5 and more preferably greater than 5.5. It should be noted that selecting a solvent and active material with high affinity for each other will result in improvement in stability. Exemplary solvents are triglyceride oil, mono and diglycerides, mineral oil, silicone oil, diethyl phthalate, polyalpha olefins, castor oil, isopropyl myristate, mono-, di- and tri-esters and mixtures thereof, fatty acids, and glycerine. The fatty acid chain can range from C4−C26 and can have any level of unsaturation. For instance, one of the following solvents can be used: capric/caprylic triglyceride commercially available as under the trade name NEOBEE® M5 (Stepan Corporation); the CAPMUL® series by Abitec Corporation (e.g., CAPMUL® MCM); isopropyl myristate; fatty acid esters of polyglycerol oligomers, e.g., R2CO—[OCH2—CH(OCOR1)—CH2O—]n, where R1 and R2 can be H or C4-C26 aliphatic chains, or mixtures thereof, and n ranges between 2 and 50, preferably 2 and 30; nonionic fatty alcohol alkoxylates like the NEODOL® surfactants by BASF; the dobanol surfactants by Shell Corporation or the BIO-SOFT® surfactants by Stepan, wherein the alkoxy group is ethoxy, propoxy, butoxy, or mixtures thereof and said surfactants can be end-capped with methyl groups in order to increase their hydrophobicity; di- and tri-fatty acid chain containing nonionic, anionic and cationic surfactants, and mixtures thereof; fatty acid esters of polyethylene glycol, polypropylene glycol, and polybutylene glycol, or mixtures thereof; polyalphaolefins such as the EXXONMOBIL PURESYM® PAO line; esters such as the EXXONMOBIL PURESYN® esters; mineral oil; silicone oils such polydimethyl siloxane and polydimethylcyclosiloxane; diethyl phthalate; di-octyl adipate and di-isodecyl adipate. In certain embodiments, ester oils have at least one ester group in the molecule. One type of common ester oil useful in the present invention are the fatty acid mono and polyesters such as cetyl octanoate, octyl isonanoanate, myristyl lactate, cetyl lactate, isopropyl myristate, myristyl myristate, isopropyl palmitate, isopropyl adipate, butyl stearate, decyl oleate, cholesterol isostearate, glycerol monostearate, glycerol distearate, glycerol tristearate, alkyl lactate, alkyl citrate and alkyl tartrate; sucrose ester and polyesters, sorbitol ester, and the like. A second type of useful ester oil is predominantly composed of triglycerides and modified triglycerides. These include vegetable oils such as jojoba, soybean, canola, sunflower, safflower, rice bran, avocado, almond, olive, sesame, persic, castor, coconut, and mink oils. Synthetic triglycerides can also be employed provided they are liquid at room temperature. Modified triglycerides include materials such as ethoxylated and maleated triglyceride derivatives provided they are liquids. Proprietary ester blends such as those sold by FINETEX as FINSOLV® are also suitable, as is ethylhexanoic acid glyceride. A third type of ester oil is liquid polyester formed from the reaction of a dicarboxylic acid and a diol. Examples of polyesters suitable for the present invention are the polyesters marketed by EXXONMOBIL under the trade name PURESYN® ESTER. Preferred examples are isopropyl myristate, C5-C50 tryglycerides (e.g., caprylic (C8) triglyceride, capric (C10) triglyceride, and a mixture thereof), D-limonene, silicone oil, and combinations thereof.
The ratio between the hydrophobic core solvent and the hydrophilic core solvent is 1:9 to 9:1 (e.g., 1:4 to 4:1 and 2:3 to 3:2). By way of illustration, the microcapsule core contains by weight a hydrophobic core solvent 10% to 90% (e.g., 20-80% and 40-60%) and a hydrophilic core solvent 10% to 90% (e.g., 20-80% and 40-60%), provided that the sum of the hydrophobic core solvent and the hydrophilic core solvent is 100% by weight of the microcapsule core.
The microcapsule core can also contains a primary or secondary alcohol or thiol having (i) a molecular weight of 32 to 500 (e.g., 46 to 400, and 46 to 300), (ii) the number of carbon atoms of 1 to 25 (e.g., 2 to 20), or (iii) a ClogP of −2 or greater (0 or greater and 2 or greater). The amount of the alcohol or thiol is 0.001 to 2% of the microcapsule composition. Examples include saturated and unsaturated, branched and linear, C6-C10 non-fatty alcohols; saturated and unsaturated, branched and linear C11-C24 fatty alcohols; ethoxylated, propoxylated, and butoxylated fatty alcohols, with single OH end groups; Guerbet alcohols such as 2-ethylhexanol and 2-heptylundecanol; Castor oil (including ricinoleic acid and its esters); Lanolin; geraniol; citronellol; isostearyl alcohol; C8 alcohol; and any combinations thereof.
When the reloadable microcapsule is dispersed in an external hydrophilic solvent, the hydrophilic core solvent diffuses to the external hydrophilic solvent as the affinity between the external hydrophilic solvent and the hydrophilic core solvent is greater than the affinity between the hydrophobic core solvent and the hydrophilic core solvent. The affinity is related to the Euclidean difference in solubility parameter described above. A small Euclidean difference indicates a strong affinity.
An active material (e.g., a fragrance) is present in the external hydrophilic solvent. In some embodiments, the active material has an affinity for the hydrophobic core solvent greater than that for either the hydrophilic core solvent or the external hydrophilic solvent, so that the active material is prone to diffuse into the microcapsule core.
In other embodiments, the active material has a weighted Hansen solubility parameter of 20 or less (e.g., 15-20), a Hansen polarizability (HP) value of 5 or less, and a Hansen h-bonding value (δH) of 10 or less (e.g., 9 or less and 8 or less).
The active material can have a water solubility 0.2 g/L or less (e.g., 0.1 g/L or less) and/or a vapor concentration at 25° C. of 100 μg/L or more (i.e., the concentration of the vapor of the ingredient in the air to which it evaporates). When the active material contains multiple fragrance ingredients, 50 wt % or more (i.e., 50-100 wt %) of the fragrance ingredients has a water solubility of 0.1 g/L or less and/or 50 wt % or less (i.e., 0-50 wt %) of the fragrance ingredients has a vapor concentration of 100 μg/L or less.
Typically, the active material (such as a fragrance) has a vapor concentration at 25° C. of 100 μg/L or greater, preferably 800 μg/L or greater.
Preferred active materials have a molecular volume of 200 nm3 or more. Molecular volume is defined as the molecular mass divided by the corresponding molecular density. It is a measure of the volume occupied by a molecule (or scaled by moles, the volume occupied by a mole of molecules) condensed phase at room temperature and at a standard atmosphere pressure. The molecular mass and the molecular density of fragrance chemicals are available from reference materials such as the CRC Handbook of Chemistry and Physics, 98th Edition (CRC Press 2017). These data are also available in the database developed by J. Baker, M. Douma, and S. Kotochigoua: the National Institute of Standards and Technology WebBook, Gathersburd, Md.
The active material can be present by weight of the microcapsule composition at a level of 0.005% to 30% (e.g., 0.01% to 20%, 0.05% to 15%, 5% to 30%, and 5% to 20%).
The weight ratio between the hydrophilic core solvent and the hydrophobic core solvent can range from 1:99 to 99:1 (e.g., 10:90 to 90:10, 30:70 to 70:30, and 40:60 to 60:40).
The microcapsule wall is formed of an encapsulating polymer. Examples of the encapsulating polymer include polyacrylate, polyurea, polyurethane, polyacrylamide, polyester, polyether, polyamide, poly(acrylate-co-acrylamide), starch, silica, gelatin and gum Arabic, alginate, chitosan, polylactide, poly(melamine-formaldehyde), poly(urea-formaldehyde), and combinations thereof.
A specific exemplary encapsulating polymer is polyurea, which is typically a product of the polymerization reaction of a polyisocyanate and a polyamine in the presence of a dispersant such as polyvinyl alcohol, condensed naphthalene sulfonate, and a combination thereof. Either aromatic polyisocyanates or aliphatic polyisocyanates can be used. Suitable aromatic polyisocyanates include those containing a phenyl, tolyl, xylyl, naphthyl, or diphenyl moiety, or a combination thereof. Examples are polyisocyanurates of toluene diisocyanate, trimethylol propane-adducts of toluene diisocyanate, methylene diphenyl diisocyanate, and trimethylol propane-adducts of xylylene diisocyanate. Suitable aliphatic polyisocyanates include a symmetric or asymmetric trimer of hexamethylene diisocyanate, a dimer of hexamethylene diisocyanate, a trimer of isophorone diisocyanate, a biuret of hexamethylene diisocyanate, and a combination thereof.
Suitable polyamines include hexamethylene diamine (“HMDA”), hexaethylenediamine, ethylenediamine, 1,3-diaminopropane, 1,4-diamino-butane, diethylenetriamine, pentaethylenehexamine, bis(3-aminopropyl)amine, bis(hexanethylene)triamine, tris(2-aminoethyl)amine, triethylene-tetramine, N,N′-bis(3-aminopropyl)-1,3-propanediamine, tetraethylenepentamine, branched polyethylenimine, chitosan, nisin, gelatin, 1,3-diamino-guanidine, 1,1-dimethylbiguanide, guanidine, arginine, lysine, ornithine, and a combination thereof.
The weight ratio between the polyisocyanate and the polyamine (e.g., HMDA) can be in the range of 99:1 to 1:99 (e.g., 50:1 to 1:50 and 20:1 to 20:1).
More microcapsule wall materials are described below and can also be found in publications such as U.S. Pat. No. 7,196,049, US 2014/0044760, WO 2014/011860, WO 2014/059087, WO 2016/049456, WO 2015/023961, and WO 2014/085287.
The reloadable microcapsule thus prepare typically has a particle size in the range of from 0.1 to 1000 microns (i.e., μm) in diameter (e.g., 0.5 to 500 microns, 1 to 200 microns, 2 to 50 microns, 5 to 25 microns, and 1 to 10 microns). The capsule size distribution can be narrow, broad, or multi-modal.
Reloadable microcapsules can be prepared following encapsulation procedures known in the art, except that the active material is not encapsulated in the procedures. See for example U.S. Pat. Nos. 5,112,688, 6,329,057, and 6,261,483. Wall forming materials (i.e., encapsulating polymers) include a melamine formaldehyde, polyurethane, polysiloxanes, polyurea, polyamide, polyimide, polyvinyl alcohol, polyanhydride, polyolefin, polysulfone, polysaccharide, protein, polypeptide, polylactide (PLA), polyglycolide (PGA), polyorthoester, polyphosphazene, silicone, lipid, modified cellulose, gum, polystyrene, polyester, polyether, and combination of these materials. Other polymeric materials that are functional are ethylene maleic anhydride copolymer, styrene maleic anhydride copolymer, ethylene vinyl acetate copolymer, and lactide glycolide copolymer. Biopolymers that are derived from alginate, chitosan, collagen, dextran, gelatin, and starch can also be used as the encapsulating materials. Additionally, capsules can be made via the simple or complex coacervation of gelatin. Preferred encapsulating wall polymers include those formed from isocyanates, acrylates, acrylamide, acrylate-co-acrylamide, hydrogel monomers, sol-gel precursors, gelatin, melamine-formaldehyde or urea-formaldehyde condensates, as well as similar types of aminoplasts.
Certain specific encapsulating polymers are described below as non-limiting examples.
Polyurea capsules each have a microcapsule wall formed of an encapsulating polymer that is the polymerization reaction product of a polyisocyanate and a polyamine/polyalcohol. See WO 2004/054362;
WO 2015/023961; and U.S. Pat. Nos. 6,340,653 and 8,299,011. In addition, the encapsulating polymer can also be prepared using a carbonyl crosslinker and a polyamine/polyalcohol.
1.1.1 Polyisocyanates
The polyisocyanates each contain two or more isocyanate (—NCO) groups. Suitable polyisocyanates include, for example, 1,5-naphthylene diisocyanate, 4,4′-diphenylmethane diisocyanate (MDI), hydrogenated MDI (H12MDI), xylylene diisocyanate (XDI), tetramethylxylol diisocyanate (TMXDI), 4,4′-diphenyldimethylmethane diisocyanate, di- and tetraalkyldiphenylmethane diisocyanate, 4,4′-dibenzyl diisocyanate, 1,3-phenylene diisocyanate, 1,4-phenylene diisocyanate, the isomers of tolylene diisocyanate (TDI), optionally in a mixture, 1-methyl-2,4-diisocyanatocyclohexane, 1,6-diisocyanato-2,2,4-trimethylhexane, 1,6-diisocyanato-2,4,4-trimethylhexane, 1-isocyanatomethyl-3-isocyanato-1,5,5-trimethylcyclohexane, chlorinated and brominated diisocyanates, phosphorus-containing diisocyanates, 4,4′-diisocyanatophenylperfluoroethane, tetramethoxybutane 1,4-diisocyanate, butane 1,4-diisocyanate, hexane 1,6-diisocyanate (HDI), dicyclohexylmethane diisocyanate, cyclohexane 1,4-diisocyanate, ethylene diisocyanate, phthalic acid bisisocyanatoethyl ester, also polyisocyanates with reactive halogen atoms, such as 1-chloromethylphenyl 2,4-diisocyanate, 1-bromomethylphenyl 2,6-diisocyanate, and 3,3-bischloromethyl ether 4,4′-diphenyldiisocyanate. Sulfur-containing polyisocyanates are obtained, for example, by reacting hexamethylene diisocyanate with thiodiglycol or dihydroxydihexyl sulfide. Further suitable diisocyanates are trimethylhexamethylene diisocyanate, 1,4-diisocyanatobutane, 1,2-diisocyanatododecane, dimer fatty acid diisocyanate, and combinations thereof.
Other suitable commercially-available polyisocyanates include products under the trade names LUPRANATE® M20 (PMDI, commercially available from BASF containing isocyanate group “NCO” 31.5 wt %), where the average n is 0.7; BAYHYDUR® N304 and BAYHYDUR® N305, which are aliphatic water-dispersible polyisocyanates based on hexamethylene diisocyanate; DESMODUR® N3600, DESMODUR® N3700, and DESMODUR® N3900, which are low viscosity, polyfunctional aliphatic polyisocyanates based on hexamethylene diisocyanate; DESMODUR® 3600 and DESMODUR® N100 which are aliphatic polyisocyanates based on hexamethylene diisocyanate, commercially available from Bayer Corporation, Pittsburgh, Pa.; PAPI™ 27 (PMDI, having an average molecular weight of 340 and containing NCO 31.4 wt %, Dow Chemical) where the average n is 0.7; MONDUR® MR (PMDI containing NCO at 31 wt % or greater, Bayer) where the average n is 0.8; MONDUR® MR Light (PMDI containing NCO 31.8 wt %, Bayer) where the average n is 0.8; MONDUR® 489 (PMDI containing NCO 30-31.4 wt %, Bayer) where the average n is 1.0; poly[(phenylisocyanate)-co-formaldehyde] (Aldrich Chemical, Milwaukee, Wis.), other isocyanate monomers such as DESMODUR® N3200 (poly(hexamethylene diisocyanate) commercially available from Bayer), and TAKENATE® D110-N (xylene diisocyanate adduct polymer commercially available from Mitsui Chemicals corporation, Rye Brook, N.Y., containing NCO 11.5 wt %), DESMODUR® L75 (a polyisocyanate base on toluene diisocyanate commercially available from Bayer), and DESMODUR® IL (another polyisocyanate based on toluene diisocyanate commercially available from Bayer).
In some embodiments, the polyisocyanate used in the preparation of the capsules of this invention is a single polyisocyanate. In other embodiments the polyisocyanate is a mixture of polyisocyanates. In some embodiments, the mixture of polyisocyanates includes an aliphatic polyisocyanate and an aromatic polyisocyanate. In particular embodiments, the mixture of polyisocyanates is a biuret of hexamethylene diisocyanate and a trimethylol propane-adduct of xylylene diisocyanate. In certain embodiments, the polyisocyanate is an aliphatic isocyanate or a mixture of aliphatic isocyanate, free of any aromatic isocyanate. In other words, in these embodiments, no aromatic isocyanate is used to prepare the polyurea/polyureathane polymers as capsule wall materials.
The average molecular weight of certain suitable polyisocyanates varies from 250 Daltons (“Da”) to 1000 Da and preferable from 275 Da to 500 Da. In general, the range of the polyisocyanate concentration varies from 0.1% to 10%, preferably from 0.1% to 8%, more preferably from 0.2 to 5%, and even more preferably from 1.5% to 3.5%, all based on the weight of the capsule delivery system.
The carbonyl crosslinkers each have at least two functional groups, e.g., a first functional group and a second functional group.
The first functional group is an electrophilic group reactive towards the polyfunctional amine or the polyfunctional alcohol to form a network of the encapsulating polymer. Examples include formyl, keto, carboxyl, a carboxylate ester group, an acyl halide group, an amide group, a carboxylic anhydride group, an alkyl halide group, an epoxide group, an aziridine group, an oxetane group, an azetidine group, a sulfonyl halide group, a chlorophosphate group, an isocyanate group, an α,β-unsaturated carbonyl group, an α,β-unsaturated nitrile group, or an α,β-unsaturated methanesulfonyl group. Preferably, the first function group is a carbonyl electrophilic group containing a carbonyl group such as formyl, keto, carboxyl, a carboxylate ester group, an acyl halide group, an amide group, a carboxylic anhydride group, an α,β-unsaturated carbonyl group, a trifluoromethanesulfonate group, and a p-toluenesulfonate group.
The second functional group is an electrophilic group reactive towards the polyfunctional amine or the polyfunctional alcohol. It can be selected from the groups listed immediately above.
Examples of a carbonyl crosslinker include glutaric dialdehyde, succinic dialdehyde, and glyoxal; as well as compounds such as glyoxyl trimer and paraformaldehyde, bis(dimethyl) acetal, bis(diethyl) acetal, polymeric dialdehydes, such as oxidized starch. Preferably the cross-linking agent is a low molecular weight, difunctional aldehyde, such as glyoxal, 1,3-propane dialdehyde, 1,4-butane dialdehyde, 1,5-pentane dialdehyde, or 1,6-hexane.
1.1.3 Polyfunctional Amines
Suitable polyfunctional amines include those described in WO 2015/023961. Examples are hexamethylenediamine, hexaethylenediamine, ethylenediamine, 1,3-diaminopropane, 1,4-diamino-butane, diethylenetriamine, pentaethylenehexamine, bis(3-aminopropyl)amine, bis(hexanethylene)-triamine, tris(2-aminoethyl)amine, triethylene-tetramine, N,N′-bis(3-aminopropyl)-1,3-propanediamine, tetraethylenepentamine, amino-2-methyl-1-propanol, chitosan, 1,3-diamino-guanidine, 1,1-dimethyl-biguanide, guanidine, arginine, lysine, histidine, ornithine, nisin, gelatin, and combinations thereof.
Other suitable polyamines include polyethylenimine and branched polyethylenimine (“BPEI”). Representative BPEI structure is shown below:
in which n is an integer from 1 to 20,000 (e.g., 1 to 10,000, 2 to 5,000, and 2 to 1,000). BPEI for use in this invention preferably has a molecular weight of 500 Da to 5,000,000 Da (e.g., 500 Da to 1,000,000 Da, 750 Da to 500,000 Da, 750 Da to 100,000 Da, and 750 Da to 50,000 Da).
BPEI are commercially available from Sigma-Aldrich (St. Louis, Mo.; average molecular weight 25,000 Da) and Polysciences Inc. (Warrington, Pa.; various products having molecular weight of 600 Da, 1200 Da, 1800 da, 10,000 Da, 70,000 Da, 750,000 Da, 250,000 Da, and 2,000,000 Da).
1.1.4 Polyfunctional alcohols
Suitable polyfunctional alcohols are also described in WO 2015/023961. Examples include pentaerythritol, dipentaerythritol, glycerol, polyglycerol, ethylene glycol, polyethylene glycol, trimethylolpropane, neopentyl glycol, sorbitol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, galactitol, fucitol, iditol, inositol, volemitol, isomalt, maltitol, lactitol, maltotriitol, maltotetraitol, polyglycitol, and combinations thereof.
A representative process used for aminoplast encapsulation is disclosed in US 2007/0078071, though it is recognized that many variations with regard to materials and process steps are possible. Another encapsulation process, i.e., gelatin encapsulation, is disclosed in U.S. Pat. No. 2,800,457. Both processes are discussed in the context of fragrance encapsulation for use in consumer products in U.S. Pat. Nos. 4,145,184 and 5,112,688 respectively. Polymer systems are well-known in the art and non-limiting examples of these include aminoplast capsules and encapsulated particles as disclosed in Application GB 2006709 A; the production of micro-capsules having walls comprising styrene-maleic anhydride reacted with melamine-formaldehyde precondensates as disclosed in U.S. Pat. No. 4,396,670; an acrylic acid-acrylamide copolymer, cross-linked with a melamine-formaldehyde resin as disclosed in U.S. Pat. No. 5,089,339; capsules composed of cationic melamine-formaldehyde condensates as disclosed in U.S. Pat. No. 5,401,577; melamine formaldehyde microencapsulation as disclosed in U.S. Pat. No. 3,074,845; amido-aldehyde resin in-situ polymerized capsules (see EP 0 158 449 A1); etherified urea-formaldehyde polymers (see U.S. Pat. No. 5,204,185); melamine-formaldehyde microcapsules as described in U.S. Pat. No. 4,525,520; cross-linked oil-soluble melamine-formaldehyde precondensates as described in U.S. Pat. No. 5,011,634; capsule wall material formed from a complex of cationic and anionic melamine-formaldehyde precondensates that are then cross-linked as disclosed in U.S. Pat. No. 5,013,473; polymeric shells made from addition polymers such as condensation polymers, phenolic aldehydes, urea aldehydes or acrylic polymers as disclosed in U.S. Pat. No. 3,516,941; urea-formaldehyde capsules as disclosed in EP 0 443 428 A2; melamine-formaldehyde chemistry as disclosed in GB 2 062 570 A; and capsules composed of polymer or copolymer of styrene sulfonic acid in acid of salt form, and capsules cross-linked with melamine-formaldehyde as disclosed in U.S. Pat. No. 4,001,140.
Urea-formaldehyde and melamine-formaldehyde pre-condensate microcapsule shell wall precursors are prepared by means of reacting urea or melamine with formaldehyde where the mole ratio of melamine or urea to formaldehyde is in the range of from about 10:1 to about 1:6, preferably from about 1:2 to about 1:5. For purposes of practicing this invention, the resulting material has a molecular weight in the range of from 156 to 3000. The resulting material may be used ‘as-is’ as a cross-linking agent for the aforementioned substituted or un-substituted acrylic acid polymer or copolymer or it may be further reacted with a C1-C6 alcohol, e.g., methanol, ethanol, 2-propanol, 3-propanol, 1-butanol, 1-pentanol or 1-hexanol, thereby forming a partial ether where the mole ratio of melamine/urea:formaldehyde:alcohol is in the range of 1:(0.1-6):(0.1-6). The resulting ether moiety-containing product may be used ‘as-is’ as a cross-linking agent for the aforementioned substituted or un-substituted acrylic acid polymer or copolymer, or it may be self-condensed to form dimers, trimers and/or tetramers which may also be used as cross-linking agents for the aforementioned substituted or un-substituted acrylic acid polymers or co-polymers. Methods for formation of such melamine-formaldehyde and urea-formaldehyde pre-condensates are set forth in U.S. Pat. Nos. 3,516,846 and 6,261,483, and Lee et al. (2002) J. Microencapsulation 19, 559-569.
Examples of urea-formaldehyde pre-condensates useful in the practice of this invention are products under URAC® 180 and URAC® 186, trademarks of Cytec Technology Corp. of Wilmington, Del. Examples of melamine-formaldehyde pre-condensates useful in the practice if this invention, include, but are not limited to, CYMEL® U-60, CYMEL® U-64 and CYMEL® U-65, trademarks of Cytec Technology Corp. of Wilmington, Del. It is preferable to use, as the precondensate for cross-linking, the substituted or un-substituted acrylic acid polymer or co-polymer. In practicing this invention, the range of mole ratios of urea-formaldehyde precondensate/melamine-formaldehyde pre-condensate to substituted/un-substituted acrylic acid polymer/co-polymer is in the range of from about 9:1 to about 1:9, preferably from about 5:1 to about 1:5 and most preferably from about 2:1 to about 1:2.
In one embodiment, microcapsules with polymer(s) composed of primary and/or secondary amine reactive groups or mixtures thereof and cross-linkers can also be used. See US 2006/0248665. The amine polymers can possess primary and/or secondary amine functionalities and can be of either natural or synthetic origin Amine-containing polymers of natural origin are typically proteins such as gelatin and albumen, as well as some polysaccharides. Synthetic amine polymers include various degrees of hydrolyzed polyvinyl formamides, polyvinylamines, polyallyl amines and other synthetic polymers with primary and secondary amine pendants. Examples of suitable amine polymers are the LUPAMIN® series of polyvinyl formamides available from BASF. The molecular weights of these materials can range from 10,000 Da to 1,000,000 Da.
Urea-formaldehyde or melamine-formaldehyde capsules can also include formaldehyde scavengers, which are capable of binding free formaldehyde. When the capsules are for use in aqueous media, formaldehyde scavengers such as sodium sulfite, melamine, glycine, and carbohydrazine are suitable. When the capsules are aimed to be used in products having low pH, e.g., fabric care conditioners, formaldehyde scavengers are preferably selected from beta diketones, such as beta-ketoesters, or from 1,3-diols, such as propylene glycol. Preferred beta-ketoesters include alkyl-malonates, alkyl aceto acetates and polyvinyl alcohol aceto acetates.
Sol-gel microcapsules each have a sol-gel polymer as the encapsulating polymer. The sol-gel polymer is the polymerization product of a sol-gel precursor, a compound capable of forming a sol-gel polymer. The sol-gel precursors are typically those containing silicon, boron, aluminum, titanium, zinc, zirconium, and vanadium. Preferred precursors are organosilicon, organoboron, organoaluminum including metal alkoxides and b-diketonates, and combinations thereof. See U.S. Pat. No. 9,532,933.
Hydrogel microcapsules are prepared using a polymerizable material such as a monofunctional or multifunctional acrylic or methacrylic acid, or ester thereof. See e.g., WO2014/011860. Exemplary materials useful for preparing hydrogel microcapsules are listed below.
1.4.1 Monomers
Preferred bi- or polyfunctional vinyl monomers include by way of illustration and not limitation, acrylic acid, methacrylic acid, 2-hydroxyethyl acrylate, methyl acrylate, ethyl acrylate, propyl acrylate, n-butyl acrylate, pentyl acrylate, hexyl acrylate, 2-ethylhexyl acrylate, heptyl acrylate, octyl acrylate, nonyl acrylate, decyl acrylate, dodecyl acrylate, tetradecyl acrylate, hexadecyl acrylate, isopropyl acrylate, isobutyl acrylate, sec-butyl acrylate, 2-ethylbutyl acrylate, 3-methylbutyl acrylate, 1-ethylpropyl acrylate, 2-methylpentyl acrylate, 2-ethylbutyl acrylate, 1,3-dimethylbutyl acrylate, 1-methylhexyl acrylate, 2-ethylhexyl acrylate, 1-methylheptyl acrylate, 4-ethyl-1-methyloctyl acrylate, 4-ethyl-1,1-isobutyloctyl acrylate, allyl acrylate, 2-methylallyl acrylate, 1-methylallyl acrylate, 2-butenyl acrylate, 1,3-dimethyl-3-dibutenyl acrylate, 3,7-dimethyl-7-octenyl acrylate, 3,7-dimethyl-2,6-octadienyl acrylate, 3,7-dimethyl-6-octenyl acrylate, tert-butyl acrylate, triethylene glycol diacrylate, triethylene glycol dimethacrylate, diethylene glycol diacrylate, diethylene glycol dimethacrylate, tripropylene glycol diacrylate, aliphatic or aromatic urethane diacrylates, difunctional urethane acrylates, ethoxylated bisphenol diacrylate, ethoxylated bisphenol dimethylacrylate, ethoxylated aliphatic difunctional urethane methacrylates, ethoxylated trimethylolpropane triacrylate, ethoxylated pentaerythritol tetraacrylate, dipropylene glycol diacrylate, aliphatic or aromatic urethane dimethacrylates, epoxy acrylates, epoxymethacrylates, tetraethylene glycol dimethacrylate, tetraethylene glycol diacrylate, polyethylene glycol dimethacrylate, polyethylene glycol diacrylate, 1,3-butylene glycol diacrylate, 1,3-butylene glycol dimethacrylate, 1,4-butanediol dimethacrylate, 1,4-butaneidiol diacrylate, 1,6-hexanediol diacrylate, 1,6-hexanediol dimethacrylate, neopentyl glycol diacrylate, alkoxylated hexanediol diacrylate, alkoxylated cyclohexane dimethanol diacrylate, propoxylated neopentyl glycol diacrylate, trimethylolpropane trimethacrylate, trimethylolpropane triacrylate, pentaerythritol triacrylate, propoxylated trimethylolpropane triacrylate, propoxylated glyceryl triacrylate, ditrimethyloipropane tetraacrylate, dipentaerythritol pentaacrylate, and the like. Representative ester monomers of methacrylic acid, which can be used include 2-hydrox ethyl methacrylate, glycidyl methacrylate, methyl methacrylate, ethyl methacrylate, n-propyl methacrylate, isopropyl methacrylate, n-butyl methacrylate, isobutyl methacrylate, sec-butyl methacrylate, tert-butyl methacrylate, n-hexyl methacrylate, n-octyl methacrylate, isooctyl methacrylate, decyl methacrylate, n-dodecyl methacrylate, n-tetradecyl methacrylate, n-hexadecyl methacrylate, 2-ethylhexyl methacrylate, allyl methacrylate, oleyl methacrylate, 2-propynyl methacrylate, 2-(dimethylamino)ethyl methacrylate, 2-(diethylamino)ethyl methacrylate, 2-(diisopropylamino)ethyl methacrylate, N-(2-aminoethyl)methacryl-amide hydrochloride, 2-aminoethyl methacrylate hydrochloride, N-(3-aminopropyl)methacrylamide hydrochloride, 2-(tert-butylamino)ethyl methacrylate, and the like.
The above monomers may be employed separately or in various mixtures. The use of multifunctional acrylate and methacrylate will lead to the formation of cross-linked network polymers upon polymerization. Such polymers have desirable properties such as good mechanical strength, elasticity, toughness, and flexibility. Examples of multifunctional acrylates and methacrylates of use in this invention include, but are not limited to, ethylene glycol dimethacrylate (“EGDMA”), trimethylol-propane trimethacrylate, trimethyloyl triacrylate, pentaerythritol triacrylate, pentaerythritol tetracrylate, bisphenol A dimethacrylate, di (trimethylolpropane) tetraacrylate (“DTTA”), 1-(acryloyloxy)-3-(methacryl-oyloxy)-2-propanol (“AOOP”), trimethylolpropane ethoxylate triacrylate (“TPETA”), dipentaerythritol pentaacrylate, hexane diacrylate, poly (ethylene glycol) dimethacrylate (“PEGDMA”), and 1,6-hexandiol dimethacrylate (“HDDMA”), 1,4-butandiol dimethacrylate, 1,3-butandiol dimethacrylate, 1,6-hexandiol diacrylate, 1,4-butandiol diacrylate, 1,3-butandiol diacrylate. In certain embodiments, the acrylic or methacrylic acid, or ester thereof, makes up less than 25% by mass, preferably 5% to 20% by mass, or more preferably 10% to 15% by mass of the oil phase.
1.4.2 Initiators Initiators are often used to start the polymerization reactions. Examples include but not limited to: AIBN, sodium persulfate, benzoyl peroxide, and ammonium persulfate.
Proteins useful in coacervation processes include albumins, vegetable globulins and gelatines. The gelatine may be fish, pork, beef, and/or poultry gelatine, for example. According to a preferred embodiment, the protein is fish, beef or poultry gelatine. According to a more preferred embodiment, the protein is warm water fish gelatine.
Typical non-protein polymers useful in complex coacervation methods include, in particular, negatively charged polymers. For example, they may be selected from gum arabic, xanthan, agar, alginate salts, cellulose derivatives, for example carboxymethyl cellulose, pectinate salts, carrageenan, polyacrylic and methacrylic acid, and/or mixtures thereof. Further suitable non-proteins can be derived from the literature, for example from to WO 2004/022221.
A cross-linking agent is typically used to harden the coating layer. Suitable cross-linking agents include formaldehyde, acetaldehyde, glutaraldehyde, glyoxal, chrome alum, or transglutaminase. Preferably, transglutaminase is used at 10-100, preferably 30-60 activity units per gram of gelatine. This enzyme is well described and commercially obtainable.
Most microcapsule formation aids are used as dispersants (namely, emulsifiers or surfactants). They facilitate the formation of stable emulsions containing nano- or micro-sized oil drops to be encapsulated. Further, microcapsule formation aids improve the performance of the microcapsule by stabilizing capsules and/or their deposition to the target areas or releasing to the environment. Performance is measured by the intensity of the fragrance release during the use experience, such as the pre-rub and post-rub phases in a laundry experience. The pre-rub phase is the phase when the microcapsules have been deposited on the cloth, e.g., after a fabric softener containing microcapsules has been used during the wash cycle. The post-rub phase is after the microcapsules have been deposited and the microcapsules are broken by friction or other similar mechanisms.
The amount of these microcapsule formation aids is anywhere from about 0.1 to about 40 percent by weight of the microcapsule, more preferably from 0.1 to about 10 percent, more preferably 0.1 to 5 percent by weight.
Preferred microcapsule formation aids are polyvinyl pyrrolidone, polyvinyl alcohol, poly(styrene sulfonate), carboxymethyl cellulose, sodium salt of naphthalene sulfonate condensate, co-polymer of ethylene and maleic anhydride, an alginate, hyaluronic acid, poly(acrylic acid), carboxymethylcellulose, copolymers of acrylic acid and acrylamide, copolymer of acrylamide and acrylamidopropyltrimonium chloride, terpolymers of (acrylic acid, acrylamide, and acrylamidopropyltrimonium chloride), partially or completely hydrolyzed polyvinyl acetate polymers (i.e., polyvinyl alcohol), and combinations thereof.
Other microcapsule formation aids include water-soluble salts of alkyl sulfates, alkyl ether sulfates, alkyl isothionates, alkyl carboxylates, alkyl sulfosuccinates, alkyl succinamates, alkyl sulfate salts such as sodium dodecyl sulfate, alkyl sarcosinates, alkyl derivatives of protein hydrolyzates, acyl aspartates, alkyl or alkyl ether or alkylaryl ether phosphate esters, sodium dodecyl sulphate, phospholipids or lecithin, or soaps, sodium, potassium or ammonium stearate, oleate or palmitate, alkylarylsulfonic acid salts such as sodium dodecylbenzenesulfonate, sodium dialkylsulfosuccinates, dioctyl sulfosuccinate, sodium dilaurylsulfosuccinate, poly(styrene sulfonate) sodium salt, isobutylene-maleic anhydride copolymer, gum arabic, sodium alginate, cellulose sulfate and pectin, isobutylene-maleic anhydride copolymer, gum arabic, carrageenan, sodium alginate, pectic acid, tragacanth gum, almond gum and agar; semi-synthetic polymers such as sulfated cellulose, sulfated methylcellulose, carboxymethyl starch, phosphated starch, lignin sulfonic acid; and synthetic polymers such as maleic anhydride copolymers (including hydrolyzates thereof), polyacrylic acid, polymethacrylic acid, acrylic acid butyl acrylate copolymer or crotonic acid homopolymers and copolymers, vinylbenzenesulfonic acid or 2-acrylamido-2-methylpropanesulfonic acid homopolymers and copolymers, and partial amide or partial ester of such polymers and copolymers, carboxymodified polyvinyl alcohol, sulfonic acid-modified polyvinyl alcohol and phosphoric acid-modified polyvinyl alcohol, phosphated or sulfated tristyrylphenol ethoxylates.
Commercially available surfactants include, but are not limited to, sulfonated naphthalene-formaldehyde condensates such as MORWET® D425 (sodium salt of alkylnaphthalenesulfonate formaldehyde condensate, Akzo Nobel, Fort Worth, Tex.); partially hydrolyzed polyvinyl alcohols such as products under the trade names of MOWIOL®, e.g., MOWIOL® 3-83 (Air Products), Ultalux® FP, Ultalux® FA, Ultalux® AD, Selvol® 203 (Sekisui), OKS-8089 (Sourus); ethylene oxide-propylene oxide block copolymers or poloxamers such as PLURONIC®, SYNPERONIC® or PLURACARE® materials (BASF); sulfonated polystyrenes such as FLEXAN® II (Akzo Nobel); ethylene-maleic anhydride polymers such as ZEMAC® (Vertellus Specialties Inc.); copolymer of acrylamide and acrylamidopropyl-trimonium chloride such as Salcare SC 60 (BASF); and Polyquaternium series such as Polyquaternium-11 (“PQ11;” a copolymer of vinyl pyrrolidone and quaternized dimethylaminoethyl methacrylate; sold by BASF as LUVIQUAT® PQ11 AT 1). Surfactant MOWIOL® 3-83 has a viscosity of 2 mPa·S to 4 mPa·S (e.g., 3 mPa·S), a degree of hydrolysis of 80-85% (e.g., 83%), an ester value of 170-210 mg KOH/g (e.g., 190 mg KOH/g), and a residual unhydrolyzed acetyl content of 13-18% (e.g., 15%).
In other embodiments, the capsule formation aid is a processing aid such as hydrocolloids, which improve the colloidal stability of the slurry against coagulation, sedimentation and creaming. The term “hydrocolloid” refers to a broad class of water-soluble or water-dispersible polymers having anionic, cationic, zwitterionic or non-ionic character. Hydrocolloids useful in the present invention include, but are not limited to, polycarbohydrates, such as starch, modified starch, dextrin, maltodextrin, and cellulose derivatives, and their quaternized forms; natural gums such as alginate esters, carrageenan, xanthanes, agar-agar, pectines, pectic acid, and natural gums such as gum arabic, gum tragacanth and gum karaya, guar gums and quaternized guar gums; gelatine, protein hydrolysates and their quaternized forms; synthetic polymers and copolymers, such as poly(vinyl pyrrolidone-co-vinyl acetate), poly(vinyl alcohol-co-vinyl acetate), poly((met)acrylic acid), poly(maleic acid), poly(alkyl(meth)acrylate-co-(meth)acrylic acid), poly(acrylic acid-co-maleic acid)copolymer, poly(alkyleneoxide), poly(vinylmethylether), poly(vinylether-co-maleic anhydride), and the like, as well as poly-(ethyleneimine), poly((meth)acryl-amide), poly(alkyleneoxide-co-dimethylsiloxane), poly(amino dimethylsiloxane), Ultrez® 20 (Acrylates/C10-30 Alkyl Acrylate Crosspolymer), Carbopol® Ultrez® 30 (cross-linked homopolymer of acrylic acid polymerized in a cyclohexane and ethyl acetate co-solvent system.), Aculyn® Excel (Acrylates Copolymer), Carbopol® 981(Carbomer), and the like, and their quaternized forms.
The capsule formation aid may also be used in combination with carboxymethyl cellulose (“CMC”), polyvinylpyrrolidone, polyvinyl alcohol, alkylnaphthalenesulfonate formaldehyde condensates, and/or a surfactant during processing to facilitate capsule formation. Examples of surfactants that can be used in combination with the capsule formation aid include, but are not limited to, cetyl trimethyl ammonium chloride (“CTAC”), poloxamers such as PLURONIC® (e.g., PLURONIC® F127), PLURAFAC® (e.g., PLURAFAC® F127), or MIRANET-N®, saponins such as QNATURALE® (National Starch Food Innovation); or a gum Arabic such as Seyal or Senegal. In certain embodiments, the CMC polymer has a molecular weight range between about 90,000 Da to 1,500,000 Da, preferably between about 250,000 Da to 750,000 Da and more preferably between 400,000 Da to 750,000 Da. The CMC polymer has a degree of substitution between about 0.1 to about 3, preferably between about 0.65 to about 1.4, and more preferably between about 0.8 to about 1.0. The CMC polymer is present in the capsule slurry at a level from about 0.1% to about 2% and preferably from about 0.3% to about 0.7%. In other embodiments, polyvinylpyrrolidone used in this invention is a water-soluble polymer and has a molecular weight of 1,000 Da to 10,000,000 Da. Suitable polyvinylpyrrolidone are polyvinylpyrrolidone K12, K15, K17, K25, K30, K60, K90, or a mixture thereof. The amount of polyvinylpyrrolidone is 2% to 50%, 5% to 30%, or 10% to 25% by weight of the capsule delivery system. Commercially available alkylnaphthalenesulfonate formaldehyde condensates include MORWET® D-425, which is a sodium salt of naphthalene sulfonate condensate by Akzo Nobel, Fort Worth, Tex.
Food-grade dispersants are envisioned. The term “food-grade dispersant” refers to a dispersant having a quality as fit for human consumption. They can be natural or non-natural products. A natural product or surfactant refers to a product that is naturally occurring and comes from a nature source. Natural products/surfactants include their derivatives which can be salted, desalted, deoiled, fractionated, or modified using a natural enzyme or microorganism. On the other hand, a non-natural surfactant is a chemically synthesized surfactant by a chemical process that does not involve an enzymatic modification.
Natural dispersants include quillaja saponin, lecithin, gum arabic, pectin, carrageenan, chitosan, chondroitin sulfate, cellulose gum, modified starch, whey protein, pea protein, egg white protein, silk protein, fish gelatin, protein of porcine or bovine origin, ester gum, fatty acid, and combinations thereof.
Non-natural dispersants include N-lauroyl-L-arginine ethyl ester, sorbitan ester, polyethoxylated sorbitan ester, polyglyceryl ester, fatty acid ester, and combinations thereof.
Other food safe dispersant can also be included in the microcapsule of this invention. Examples include ammonium phosphatides, acetic acid esters of mono- and diglycerides (Acetem), lactic acid esters of mono- and diglycerides of fatty acids (Lactem), citric acid esters of mono and diglycerides of fatty acids (Citrem), mono and diacetyl tartaric acid esters of mono and diglycerides of fatty acids (Datem), succinic acid esters of monoglycerides of fatty acids (SMG), ethoxylated monoglycerides, sucrose esters of fatty acids, sucroglycerides, polyglycerol polyricinoleate, propane-1,2-diol esters of fatty acids, thermally oxidized soya bean oil interacted with mono- or diglycerides of fatty acids, sodium stearoyl lactylate (SSL), calcium stearoyl lactylate (CSL), stearyl tartrate, polyglycerol esters of interesterified castor oil acid (E476), sodium stearoyllatylate, sodium lauryl sulfate, polyoxyethylated hydrogenated castor oil (for instance, such sold under the trade name CREMO-PHOR®), block copolymers of ethylene oxide and propylene oxide (for instance as sold under the trade name PLURONIC® or the trade name POLOXAMER®), polyoxyethylene fatty alcohol ethers, and polyoxyethylene stearic acid ester.
The Encapsulating polymer can also include one or more additional wall polymers, e.g., a second, third, fourth, fifth, or sixth polymer. The additional polymers can be selected from the group consisting of silica, polyacrylate, polyacrylamide, poly(acrylate-co-acrylamide), polyurea, polyurethane, starch, gelatin and gum Arabic, poly(melamine-formaldehyde), poly(urea-formaldehyde), and combinations thereof.
Conventional encapsulation methods can be used to prepare the reloadable microcapsules. See WO 2015/023961.
By way of illustration, to prepare a reloadable microcapsule having a polyurea encapsulating polymer, an oil-in-water emulsion is first prepared containing (i) a polyamine, a polyalcohol, or mixture thereof, (ii) a polyisocyanate, carbonyl crosslinker, or mixture thereof, (iii) an oil phase having a hydrophilic core solvent and a hydrophobic core solvent, and (iv) an aqueous phase having a microcapsule formation aid and water. The reaction between the polyamine/polyalcohol and the polyisocyanate/carbonyl crosslinker occurs when the temperature of the reaction mixture is raised or a catalyst (such as a transglutaminase for catalyzing amide formation) is added to the mixture.
Catalysts suitable for use in the polyurea/polyurethane formation are transglutaminases, metal carbonates, metal hydroxide, amino or organometallic compounds and include, for example, sodium carbonate, cesium carbonate, potassium carbonate, lithium hydroxide, 1,4-diazabicyclo[2.2.2]octane (i.e., DABCO), N,N-dimethylaminoethanol, N,N-dimethylcyclohexylamine, bis-(2-dimethylamino-ethyl) ether, N,N dimethylacetylamine, stannous octoate and dibutyltin dilaurate.
The resultant microcapsule slurry is then cured at a predetermined temperature for a predetermined period of time.
In accordance with some embodiments, the microcapsules prepared according to the methods above are cured at a temperature in the range of, e.g., 15° C. to 230° C. (e.g., 55° C. to 90° C., 55° C. to 75° C., and 90° C. to 130° C.) for 1 minute to 10 hours (e.g., 0.1 hours to 5 hours, 0.2 hours to 4 hours and 0.5 hours to 3 hours). A skilled person in the art can determine, without undue experiments, the curing temperature, duration, and the heating rate.
To obtain microcapsules with more leaching of the active material, certain embodiments of this invention provide for a cure at a low temperature, e.g., less than 100° C. In some embodiments, the cure temperature is at or less than 90° C. In other embodiments, the cure temperature is at or less than 80° C.
In one embodiment, the capsules are heated to a target cure temperature at a linear rate of 0.5° C. to 2° C. per minute (e.g., 1° C. to 5° C. per minute, 2° C. to 8° C. per minute, and 2° C. to 10° C. per minute) over a period of 1 minute to 60 minutes (e.g., 1 minute to 30 minutes). The following heating methods may be used: conduction for example via oil, steam radiation via infrared, and microwave, convection via heated air, steam injection and other methods known by those skilled in the art. The target cure temperature used herein refers to the minimum temperature in degrees Celsius at which the capsules may be cured to retard leaching.
The microcapsule compositions of the invention have one or more active materials in the external hydrophilic solvent. Nonlimiting examples include those described in WO 2016/049456. These active material include a fragrance, pro-fragrance, flavor, malodor counteractive agent, vitamin or derivative thereof, anti-inflammatory agent, fungicide, anesthetic, analgesic, antimicrobial active, anti-viral agent, anti-infectious agent, anti-acne agent, skin lightening agent, insect repellent, animal repellent, vermin repellent, emollient, skin moisturizing agent, wrinkle control agent, UV protection agent, fabric softener active, hard surface cleaning active, skin or hair conditioning agent, flame retardant, antistatic agent, taste modulator, cell, probiotic, antioxidant, self-tanning agent, dihydroxyacetone, cooler, sensate, malodor reactive material, cosmetic active, and combinations thereof. Cosmetic actives include vitamins, sun filters and sunscreens, anti-aging agents, anti-wrinkle agents, antioxidants, lifting agents, firming agents, anti-spot agents, anti-redness agents, thinning agents, draining agents, moisturizers, soothing agents, scrubbing or exfoliating agents, mattifying agents, sebum regulating agents, skin-lightening actives, self-tanning actives, tanning accelerators and combinations thereof. In addition to the active materials listed above, the products of this invention can also contain dyes, colorants or pigments, naturally obtained extracts (for example paprika extract and black carrot extract), and aluminum lakes. The microcapsule compositions of the invention are particularly suitable for encapsulating fragrances containing one or more aldehydes, amines, and/or alcohols. Aldehydes/amines/alcohols can react with microcapsule wall forming materials such as polyisocyanates, silicate, acrylates, etc.
In some embodiments, the amount of active material in the microcapsule composition is from 0.1% to 95% (e.g., 0.5% to 10%, 1% to 90%, 2% to 80%, 4% to 70%, and 5 to 50%) by weight of the composition. The amount of the capsule wall is from 1% to 98% (e.g., 1% to 50%, 2% to 20%, and 3% to 15%) by weight of the capsule. The amount of the microcapsule core is from 10% to 99% (e.g., 20% to 95%, 50% to 95%, and 80% to 95%) by weight of the capsule.
In some microcapsule compositions, the ratio between the capsule and active material is 1:2 to 40:1 (e.g., 1:1 to 30:1 and 1:1 to 20:1).
In addition to the active materials, the present invention also contemplates the incorporation of adjunct materials including solvent, emollients, and core modifier materials in the core encapsulated by the capsule wall. Other adjunct materials are nanoscale solid particulate materials, polymeric core modifiers, solubility modifiers, density modifiers, stabilizers, humectants, viscosity modifiers, pH modifiers, or any combination thereof. These modifiers can be present in the wall or core of the capsules, or outside the capsules in delivery system. Preferably, they are in the core as a core modifier.
The one or more adjunct material may be added in the amount of from 0.01% to 25% (e.g., from 0.5% to 10%) by weight of the capsule.
Suitable examples include those described in WO 2016/049456 and US 2016/0158121.
A capsule deposition aid from 0.01% to 25%, more preferably from 5% to 20% can be included by weight of the capsule. The capsule deposition aid can be added during the preparation of the capsules or it can be added after the capsules have been made.
These deposition aids are used to aid in deposition of capsules to surfaces such as fabric, hair or skin. These include anionically, cationically, nonionically, or amphoteric water-soluble polymers. Suitable deposition aids include polyquaternium-4, polyquaternium-5, polyquaternium-6, polyquaternium-7, polyquaternium-10, polyquaternium-16, polyquaternium-22, polyquaternium-24, polyquaternium-28, polyquaternium-39, polyquaternium-44, polyquaternium-46, polyquaternium-47, polyquaternium-53, polyquaternium-55, polyquaternium-67, polyquaternium-68, polyquaternium-69, polyquaternium-73, polyquaternium-74, polyquaternium-77, polyquaternium-78, polyquaternium-79, polyquaternium-80, polyquaternium-81, polyquaternium-82, polyquaternium-86, polyquaternium-88, polyquaternium-101, polyvinylamine, polyethyleneimine, polyvinylamine and vinylformamide copolymer, an acrylamidopropyltrimonium chloride/acrylamide copolymer, a methacrylamidopropyltrimonium chloride/acrylamide copolymer, polymer comprising units derived from polyethylene glycol and terephthalate, polyester, polymer derivable from dicarboxylic acids and polyols, and combinations thereof. the polyester substantive deposition aid is a phthalate containing polymer, more preferably a polymer comprising units derived from (poly)ethylene glycol and terephthalate, most preferably selected from the group comprising PET/POET, PEG/POET, PET/PEG and phthalate/glycerol/ethylene glycol polymers as described in WO 2009037060. Other suitable deposition aids include those described in WO 2016049456, pages 13-27. Additional deposition aids are described in US 2013/0330292, US 2013/0337023, and US 2014/0017278.
The reloadable microcapsule can be formulated into a capsule delivery system (e.g., a microcapsule composition) for use in consumer products.
The capsule delivery system can be a slurry containing in an external hydrophilic solvent (e.g., water, ethanol, and a combination thereof) the capsule at a level 0.1% to 80% (e.g., 70-75%, 40-55%, 50-90%, 1-65%, and 5-45%) by weight of the capsule delivery system.
In some embodiments, the capsule and its slurry prepared in accordance with the present invention is subsequently purified. See US 2014/0017287. Purification can be achieved by washing the capsule slurry with water until a neutral pH is achieved.
The capsule delivery system can also contain one or more other delivery system such as polymer-assisted delivery compositions (see U.S. Pat. No. 8,187,580), fiber-assisted delivery compositions (US 2010/0305021), cyclodextrin host guest complexes (U.S. Pat. No. 6,287,603 and US 2002/0019369), pro-fragrances
(WO 2000/072816 and EP 0 922 084), and any combination thereof. The capsule delivery system can also contain one or more (e.g., two, three, four, five or six more) different capsules including different capsules of this invention and other capsules such as such as aminoplasts, hydrogel, sol-gel, polyurea/polyurethane capsules, and melamine formaldehyde capsules. More exemplary delivery systems that can be incorporated are coacervate capsules (see WO 2004/022221) and cyclodextrin delivery systems (see WO 2013/109798 and US 2011/03085560).
Any compound, polymer, or agent discussed above can be the compound, polymer, or agent itself as shown above, or its salt, precursor, hydrate, or solvate. A salt can be formed between an anion and a positively charged group on the compound, polymer, or agent. Suitable anions include chloride, bromide, iodide, sulfate, nitrate, phosphate, citrate, methanesulfonate, trifluoroacetate, acetate, malate, tosylate, tartrate, fumurate, glutamate, glucuronate, lactate, glutarate, and maleate. Likewise, a salt can also be formed between a cation and a negatively charged group on the compound, polymer, or agent. Suitable cations include sodium ion, potassium ion, magnesium ion, calcium ion, and an ammonium cation (e.g., tetramethylammonium ion). A precursor can be ester and another suitable derivative, which, during the process of preparing a polyurea or polyurethane capsule composition of this invention, is capable of converting to the compound, polymer, or agent and being used in preparing the polyurea or polyurethane capsule composition. A hydrate refers to the compound, polymer, or agent that contains water. A solvate refers to a complex formed between the compound, polymer, or agent and a suitable solvent. A suitable solvent can be water, ethanol, isopropanol, ethyl acetate, acetic acid, and ethanolamine
Certain compounds, polymers, and agents have one or more stereocenters, each of which can be in the R or S configuration, or a mixture. Further, some compounds, polymers, and agents possess one or more double bonds wherein each double bond exists in the E (trans) or Z (cis) configuration, or combinations thereof. The compounds, polymers, and agents include all possible configurational stereoisomeric, regioisomeric, diastereomeric, enantiomeric, and epimeric forms as well as any mixtures thereof. As such, lysine used herein includes L-lysine, D-lysine, L-lysine monohydrochloride, D-lysine monohydrochloride, lysine carbonate, and so on. Similarly, arginine includes L-arginine, D-arginine, L-arginine monohydrochloride, D-arginine monohydrochloride, arginine carbonate, arginine monohydrate, and etc. Guanidine includes guanidine hydrochloride, guanidine carbonate, guanidine thiocyanate, and other guanidine salts including their hydrates. Ornithine includes L-ornithine and its salts/hydrates (e.g., monohydrochloride) and D-ornithine and its salts/hydrates (e.g., monohydrochloride).
Structural agents are used in the fragrance composition to modify the viscosity, stabilize the composition, and improve spray properties of the composition.
The structural agent is typically present in an amount ranging from 0.01% to 5%, in some embodiments from 0.1% to 3%, based on the total weight of the composition.
Representative structural agents include nonionic, anionic, cationic, and amphoteric polymers, and other rheology modifiers such as cellulose-based thickeners (e.g., hydroxyethylcellulose, hydroxypropylcellulose, carboxymethylcellulose, cationic cellulose ether derivatives, quaternized cellulose derivatives, etc.), guar gum and its derivatives, gums of microbial origin (e.g., xanthan gum, scleroglucan gum, etc.), and gums derived from plant exudates (e.g., gum arabic, carrageenan gum, agar gum and carob gum), pectins, alginates, and starches.
Additional examples include Carbopol® ETD-2020 (acrylic acid/C10-C30 alkyl methacrylate crosslinked copolymer); Carbopol® 1382, Ultra-Thix′ P-100 by Ashalnd and the ACULYN® 22, 28, 44 and 46N sold Dow Chemical.
Other examples include anionic thickening polymers sold by the company ALLIED COLLOIDS under the names SALCARE® SC 80 and SALCARE® SC 90, aqueous emulsions containing 30% of a crosslinked terpolymer of methacrylic acid, of ethyl acrylate and of steareth-10-allyl ether (40/50/10).
Other suitable structural agents are anionic thickening polymers containing at least one fatty chain such as (1) maleic anhydride/C30-38-α-olefin/isopropyl maleate copolymer sold under the name PERFORMA®1608 from NEWPHASE TECHNOLOGIES; (2) acrylic terpolymers formed from: (a) 20% to 70% by weight of a carboxylic acid with α,β-monoethylenic unsaturation; (b) 20% to 80% by weight of a nonsurfactant monomer with α,β-monoethylenic unsaturation different from (a); and (c) 0.5% to 60% by weight of a nonionic monourethane;
Another class named associative polymers include polyurethanes, cellulose derivatives which are cationic or nonionic, associative vinyllactams, associative unsaturated polyacids, associative aminoplast ethers, and associative polymers or copolymers containing at least one monomer comprising ethylenic unsaturation. A representative example of an associative polyurethane terpolymer as a 25 percent aqueous dispersion, known by the trade name, Viscophobe® DB 1000 and commercially available from Amerchol. Representative examples of associative celluloses include quaternized cationic celluloses and quaternized cationic hydroxyethylcelluloses modified by groups containing at least one hydrophobic chain, such as alkyl, arylalkyl or alkylaryl groups containing at least 8 carbon atoms, and mixtures thereof. Representative examples of quaternized alkylhydroxy-ethylcelluloses containing a C8-C30 hydrophobic chain include the products Quatrisoft® LM 200, Quatrisoft® LM-X 529-18-A, Quatrisoft® LM-X 529-18B (Cu alkyl) and Quatrisoft® LM-X 529-8 (C18 alkyl) sold by Amerchol and the products Crodacel® QM, Crodacel® QL (C1-2 alkyl) and Crodacel® QS (C18 alkyl) sold by Croda. Representative examples of nonionic cellulose derivatives include hydroxyethylcelluloses modified by groups comprising at least one hydrophobic chain, such as alkyl, arylalkyl or alkylaryl groups, or their blends, such as the product Natrosol® Plus Grade 330 CS (C1-6 alkyls) sold by Aqualon or the product Bermocoll® EHM 100 sold by Berol Nobel.
Associative polyvinyllactams, representative examples include poly(vinyllactam) polymers, of Vinylpyrrolidone/dimethylaminopropylmethacrylamide dodecyldimethyl methacryl amidopropyl-ammonium tosylate terpolymers, vinylpyrroidone/dimethylaminopropylmethacrylamide cocoyl dimethyl methacryl amidopropylammonium tosylate terpolymers or vinylpyrrolidone dimethyl aminopropyl methacryl amide/lauryldimethylmethacrylamidopropylammonium tosylate or chloride terpolymers. The vinyl pyrrolidone/dimethylaminopropylmethacrylamide/lauryldimethyl methacryl amido propyl ammonium chloride terpolymer by Ashalnd under the name Styleze® W20.
Examples of associative polymers comprising an aminoplast ether backbone include the products Pure-Thix® L, Pure-Thix® M, Pure-Thix® HH, Pure-Thix® TX-1442, Sepimax™ Zen.
The inorganic/mineral like structural agents include clays, fumed silicas and specialty clays. Common types of modified and unmodified inorganic rheology modifiers are attapulgite clays, bentonite clays, organoclays, and synthetic silicas. They usually function as suspending or gelling agents. Inorganic rheology modifiers are thixotropes. Some mineral types are useful for thickening aqueous systems and others for solvent-based coatings. It depends mostly on the thickener's particle surface, which can be organically modified to render it hydrophobic for solvent-based coatings. Inorganic rheology modifiers are sometimes added to aqueous formulations as secondary thickeners to improve the anti-sag, anti-settling and anti-synerisis properties of a formulation. Examples are Efka® RM1900 and 1920 from BASF, Rheoluxe® 880, 812, 8015, Bentone® SD-1, Bentone® Gel MSO V/ABO/IHD V and other grades, Hectorite organoclays from Elementis, Laponite® XLG, XR, XLS, XL21, D by BYK Chemie etc.
Representative examples of surfactants useful in the fragrance composition include non-ionic amphiphilic and anionic amphiphilic ones.
Nonionic amphiphilic surfactants include 1) silicones; 2) amphiphilic lipids chosen from the esters of at least one polyol chosen from the group formed by polyethylene glycol containing from 1 to 60 ethylene oxide units, sorbitan, glycerol containing from 2 to 30 ethylene oxide units, polyglycerols containing from 2 to 15 glycerol units, and of at least one fatty acid containing at least one saturated or unsaturated, linear or branched C8-C22 alkyl chain; 3) mixed esters of fatty acid or of fatty alcohol, of carboxylic acid and of glycerol; 4) fatty acid esters of sugars and fatty alcohol ethers of sugars; 5) surfactants that are solid at a temperature of less than or equal to 45° C., chosen from fatty esters of glycerol, fatty esters of sorbitan and oxyethylenated fatty esters of sorbitan, ethoxylated fatty ethers and ethoxylated fatty esters; and 6) block copolymers of ethylene and of propylene oxide.
Representative examples of silicone surfactants include silicone compounds of the invention which may be used are commercially available under Dow Corning® DC 5225C, DC5329, DC 7439-146, DC2-5695 and Q4-3667.
Representative examples of amphiphilic lipids are polyethylene glycol (“PEG”) 400 from Unichema; diglyceryl isostearate by Solvay; glyceryl laurate by Solvay; sorbitan oleate, sold under the name Span® 80 by ICI; sorbitan isostearate, sold under the name Nikkol® SI 10R by Nikko; and a-butyl-glucoside cocoate or a-butylglucoside caprate, sold by Ulice.
Representative examples of mixed esters of fatty acid or of fatty alcohol, of carboxylic acid and of glycerol include mixed esters of fatty acid or of fatty alcohol with an alkyl chain containing from 8 to 22 carbon atoms, and of a-hydroxy acid and/or of succinic acid, with glycerol. The a-hydroxy acid may be, for example, citric acid, lactic acid, glycolic acid or malic acid, and mixtures thereof.
The alkyl chain of the fatty acids or alcohols from which are derived the mixed esters may be linear or branched, and saturated or unsaturated. They may be stearate, isostearate, linoleate, oleate, behenate, arachidonate, palmitate, myristate, laurate, caprate, isostearyl, stearyl, linoleyl, oleyl, behenyl, myristyl, lauryl or capryl chains, and mixtures thereof.
Representative examples of mixed esters include the following: the mixed ester of glycerol and of the mixture of citric acid, lactic acid, linoleic acid and oleic acid (Glyceryl citrate/lactate/linoleate/oleate) sold by Hills under the name Imwitor® 375; the mixed ester of succinic acid and of isostearyl alcohol with glycerol (Isostearyl diglyceryl succinate) sold by Hills under the name Imwitor® 780K; the mixed ester of citric acid and of stearic acid with glycerol (Glyceryl stearate citrate) sold by the company Hills under the name Imwitor® 370; the mixed ester of lactic acid and of stearic acid with glycerol (Glyceryl stearate lactate) sold by Danisco under the name Lactodan® B30 or Rylo® LA30.
Representative examples of fatty acid esters of sugars, include esters or mixtures of esters of C8-C22 fatty acid of sucrose, of maltose, of glucose or of fructose, and esters or mixtures of esters of C14-C22 fatty acid and of methylglucose.
The C8-C22 or C14-C22 fatty acids forming the fatty unit of the esters contain a saturated or unsaturated linear alkyl chain. The fatty unit of the esters may be chosen from stearates, behenates, arachidonates, palmitates, myristates, laurates and caprates, and mixtures thereof.
Such products sold by the company Croda under the name Crodesta® F50, F70, F110 and F160 having, respectively, an HLB (hydrophilic lipophilic balance) of 5, 7, 11 and 16.
The C8-C22 or C14-C22 fatty alcohols forming the fatty unit of the ethers contain a saturated or unsaturated, linear alkyl chain containing, respectively, from 8 to 22 or from 14 to 22 carbon atoms. The fatty unit of the ethers may be chosen from decyl, cetyl, behenyl, arachidyl, stearyl, palmityl, myristyl, lauryl, capryl and hexa-decanoyl units, and mixtures thereof, such as cetearyl.
Specific examples of fatty alcohol ethers of sugars include alkylpolyglucosides which are sold, for example, by the company Henkel under the respective names Plantaren® 2000 and Plantaren® 1200, or under the name Montanov® 68 by SEPPIC and under the name Tego® Care CG90 by Goldschmidt.
Fatty esters of glycerol, which are typically solid at a temperature of less than or equal to 45° C., include esters formed from at least one acid comprising a saturated linear alkyl chain containing from 16 to 22 carbon atoms and from 1 to 10 glycerol units, such as stearates, behenates, arachidates and palmitates, and mixtures thereof. Other examples include decaglyceryl monostearate, distearate, tristearate and pentastearate (product sold by the company Nikko under the name Nikkol® DGMS).
Fatty esters of sorbitan, which are typically solid at a temperature of less than or equal to 45° C., include C16-C22 fatty acid esters of sorbitan and oxyethylenated C16-C22 fatty acid esters of sorbitan. Examples include Span™ 60, Span™ 40, sold by the company ICI.
Ethoxylated fatty ethers, include ethers formed from 1 to 100 ethylene oxide units and from at least one fatty alcohol chain containing from 16 to 22 carbon atoms. The products sold under the names Nikkol® BB5-BB30 by Nikko, and under the name Brij® 72 by ICI.
Representative examples of ethoxylated fatty esters, which are typically solid at a temperature of less than or equal to 45° C., include esters formed from 1 to 100 ethylene oxide units and from at least one fatty acid chain containing from 16 to 22 carbon atoms. The fatty chain in the esters may be chosen from stearate, behenate, arachidate and palmitate units, and mixtures thereof. Specific examples of ethoxylated fatty esters include the ester of stearic acid containing 40 ethylene oxide units, such as the product sold under the name Myrjm™ 52 (CTFA name: PEG-40 stearate) by the company ICI, as well as the ester of behenic acid containing 8 ethylene oxide units (CTFA name: PEG-8 behenate), such as the product sold under the name Compritol® HD5 ATO by the company Gattefosse.
Representative examples of block copolymers of ethylene oxide (A) and of propylene oxide (B), include poloxamers such as Poloxamer® 231, Pluronic® L81, Poloxamer® 282, Pluronic® L92 and Poloxamer® 124 and Pluronic® L44.
The fragrance compositions of the invention are well-suited for use, without limitation, as a sprayable fine fragrance products, and also to be incorporated into the following products:
The above-listed applications are all well known in the art. For example, fabric softener systems are described in U.S. Pat. No. 6,335,315. Liquid laundry detergents include those systems described in U.S. Pat. No. 5,929,022. Liquid dish detergents are described in U.S. Pat. No. 6,069,122. Shampoo and conditioners that can employ the present invention include those described in U.S. Pat. No. 6,162,423. Automatic Dish Detergents are described in U.S. Pat. No. 6,020,294.
The terms “polyfunctional isocyanate,” “multifunctional isocyanate,” and “polyisocyanate” all refer to a compound having two or more isocyanate (—NCO) groups.
The terms “polyfunctional amine,” “multifunctional amine,” and “polyamine” refer to a compound having two or more primary or secondary amine groups. These terms also refer to a compound containing one or more primary/secondary amine groups and one or more hydroxyl groups (—OH).
The terms “microcapsule” and “capsule” are used herein interchangeably.
The terms “polyfunctional alcohol,” “multifunctional alcohol,” “poly alcohol,” and “polyol” refer to a compound having two or more hydroxyl groups.
The invention is described in greater detail by the below non-limiting examples. Without further elaboration, it is believed that one skilled in the art can, based on the description herein, utilize the present invention to its fullest extent. All publications cited herein are incorporated by reference in their entirety.
A reloadable microcapsule of this invention, i.e., Capsule 1, was prepared following the procedure described below.
More specifically, an oil phase was prepared by mixing 120 g of caprylic/capric triglyceride mixture (NEOBEE® oil, commercially available from Stepan, Chicago, Ill.; a mixture of), and 9.6 g of polymeric methylene diphenyl diisocyanate (LUPRANATE® M20, BASF corporation, Wyandotte, Mich.).
In a separate beaker, a 1% surfactant solution (160 g) was prepared by dissolving 1.6 g of a sodium salt of naphthalene sulfonate condensate (MORWET® D-425, Akzo Nobel, Fort Worth, Tex.) in water. The oil phase was then emulsified into the surfactant solution to form an oil-in-water emulsion under shearing at 9500 rpm for two minutes.
The oil-in-water emulsion was placed in a round bottom vessel and 10.8 g of 40% hexamethylene diamine (HMDA) aqueous solution (INVISTA, Wichita, Kans.) was added under constant mixing with an overhead mixer. The mixer speed was reduced after the addition of HMDA was complete. The capsule slurry was cured at 55° C. for three hours to obtain Capsule 1. This reloadable microcapsule has (i) a microcapsule wall formed of polyurea and (ii) a microcapsule core consisting of a hydrophobic core solvent (Neobee® oil).
The size of the capsule was measure to be in the range of 5-10 microns using a dynamic light scattering (DLS) instrument.
Capsule 2 of this invention was prepared following the same procedure described in Example 1 except that 120 g of triethyl citrate (Vertellus Performance Materials Inc. Greensboro, N.C.) was used instead of Neobee® oil.
Capsule 2 has (i) a microcapsule wall formed of polyurea and (ii) a microcapsule core consisting of a hydrophilic core solvent (triethyl citrate).
The size of the capsule was measure to be in the range of 5-10 microns using an DLS instrument.
Capsule 3 of this invention was prepared following the same procedure described in Example 1 except that a mixture of 60 g of triethyl citrate and 60 g of Neobee® oil was used instead of Neobee® oil.
Capsule 3 has (i) a microcapsule wall formed of polyurea and (ii) a microcapsule core consisting of a hydrophilic core solvent (triethyl citrate) and a hydrophobic core solvent (Neobee oil).
The average particle size of the capsule was measure to be in the range of 5-10 microns using an DLS instrument.
Performance of Reloadable Capsules Blended with Fragrance in Aerosol Base
To establish the consumer benefit of Capsules 1-3, these three reloadable microcapsules in the slurry as prepared each were added, together with fragrance Apple (International Flavors and Fragrance, Union Beach, N.J.), to an aerosol base to obtain three microcapsule compositions, i.e., S1-S3 respectively. Each microcapsule composition contains by weight 4% fragrance, 12.5% capsule slurry and 83.5% aerosol. The composition of the aerosol is provided in Table 1.
A control composition, i.e., Comparative Composition 51′, was prepared by mixing 4% fragrance Apple alone with the aerosol base.
Each of S1-S3 and SF (1 g) was sprayed onto a baby T-shirt. Eight T-shirts were evaluated per microcapsule composition by 15 trained judges. The judges rated the fragrance intensity 5 hours after spraying the microcapsule composition and then rubbing (post-rub) the T-shirt for 5 times. The fragrance intensity was rated at a scale ranging from 0 to 10. A numerical value of 2 indicates that the composition produces a weak intensity. A value of 10 indicates that the composition generates a very strong smell.
The sensory results are given in Table 2. The analysis indicated that reloadable capsule compositions (S1-S3) provided significantly greater post-rub fragrance intensity as compared to neat fragrance in Comparative Composition 51′).
A fourth reloadable microcapsule, i.e., Capsule 4, was prepared following the procedure below. NEOBEE® oil (120 g) and triethyl citrate (120 g) were combined with 4.8 g of isocyanate monomer, LUPRANATE® M20 to form an oil phase. In a separate beaker, a 0.5% surfactant solution (319.2 g) was prepared by dissolving 1.6 g of Mowiol® 3-85, a partially hydrolyzed polyvinyl alcohol (Kuraray, Houston, Tex.) in water. The oil phase was then emulsified into the surfactant solution to form an oil-in-water emulsion under shearing at 3000 rpm for three minutes.
To the oil-in-water emulsion was added 36 g of 6% HMDA aqueous solution under agitation. The resultant capsule slurry was cured at 55° C. for three hours to obtain Capsule 4. The average particle size of the capsule was measure to be 30 microns using a DLS instrument.
Capsules 5-8 of this invention were prepared following the same procedure described in Example 4 except that different core solvents were used.
Capsule 5 was prepared using 60 g of triacetin and 180 g of NEOBEE® oil.
Capsule 6 was prepared using 60 g of triacetin and 180 g of isopropyl myristate.
Capsule 7 was prepared using 60 g of triethyl citrate and 180 g of isopropyl myristate.
Capsule 8 was prepared using 60 g of triethyl citrate and 180 g of NEOBEE® oil.
Each of Capsules 5-8 had an average particle size of 30 microns measured using an DLS instrument.
The Hansen solubility parameters of the core solvents are shown in Table 3 below.
In some embodiments, the hydrophilic core solvent has a water solubility in the range of 0.02 to 300 g/L (e.g., 0.1 to 200 g/L and 1 to 100 g/L) and a weighted Hansen solubility parameter of 18 or greater. In other embodiments, the hydrophilic core solvent has a Hansen polarizability (dP) of 4 or greater and a Hansen h-bonding value (dH) of 5 or greater. In still other embodiments, the hydrophobic core solvent has a weighted Hansen solubility parameter of 18 or less, a Hansen polarizability (dP) of 4 or less, and a Hansen h-bonding value (dH) of 5 or less. The core solvents used to prepare Capsules 1-8 fall within the above described ranges.
To establish the consumer benefit of reloadable microcapsules, Capsules 4-7 each were mixed with fragrance Apple and then added to an alcohol body spray base (95 wt % ethanol/5 wt % water) to obtain four microcapsule compositions, i.e., S4-S7 respectively. Each microcapsule composition contained by weight 1.5% fragrance, 4.7% capsule slurry and 93.8% alcohol body spray base.
A control composition, i.e., Comparative Composition S2′, was prepared by mixing 1.5% fragrance Apple alone with the alcohol body spray base.
Each of S4-S7 and S2′ (0.5 g) was sprayed onto a lycra clothes. The clothes were allowed to dry for 24 hours. A panel of 7 judges evaluated the samples and rated the fragrance intensity both prior to rubbing (pre-rubbing) the clothes and after rubbing it (post-rubbing) for 5 times. The fragrance intensity was rated at a scale ranging from 0 to 10. A numerical value of 2 indicates that the composition produces a weak intensity. A value of 10 indicates that the composition generates a very strong smell.
The sensory results are given in Table 4. The analysis indicated that reloadable capsule compositions (S4-S7) provided significantly greater pre-rubbing and post-rubbing fragrance intensity as compared to neat fragrance in Comparative Composition S2′).
The slurry of Capsule 4 was mixed with fragrance Apple and then added to an aerosol base to obtain microcapsule composition S8. Table 5 below shows the components of S8.
A control composition, i.e., Comparative Composition S3′, was prepared by mixing 1.5% fragrance Apple alone with the aerosol base.
Each of S8 and S3′ (1 g) was sprayed onto a forearm of a panelist. After 5 hours, the panelist was instructed to briefly rub the forearm and rate the fragrance intensity (post-rubbing) at a scale ranging from 0 to 100. A numerical value of 6 indicates that the composition produces a weak intensity. A value of 17 indicates that the composition generates a strong smell. A value of 35 designates a very strong smell.
The sensory results are shown in Table 6. The analysis indicated that reloadable capsule composition S8 provided significantly greater post-rubbing fragrance intensity as compared to neat fragrance in Comparative Composition S3′).
The following evaluation shows the benefit of using reloadable capsules to delivery aldehyde fragrance ingredients. It is known that aldehydes react with microcapsule wall-forming materials such as polyisocyanate and polyamine Encapsulating aldehydes or alcohols using polyurea chemistry is very challenging. The following example provides an effective method to deliver an aldehyde-containing fragrance using reloadable microcapsules.
The slurry of Capsule 4 was mixed with a research fragrance containing an aldehyde (i.e., Fragrance D), and then blended into an aerosol base to obtain microcapsule composition S9, which contains 1.5% fragrance, 4.7% Capsule 4, and 93.8% alcohol body spray base (95% ethanol/5% water). For comparison, Comparative Composition S4′ was prepared using Fragrance D alone at 1.5% in the alcohol body spray base.
Each of S9 and S4′ (0.5 g) was sprayed onto a piece of lycra clothes. The piece of clothes was allowed to dry for 24 hours. A panel of 9 judges evaluated the samples and rated the fragrance intensity both prior to rubbing (pre-rubbing) the clothes and after rubbing it (post-rubbing) for 5 times. The fragrance intensity was rated at a scale ranging from 0 to 10. A numerical value of 2 indicates that the composition produces a weak intensity. A value of 10 indicates that the composition generates a very strong smell.
The sensory results are given in Table 7. The analysis indicated that reloadable capsule composition S9 successfully delivered aldehyde-containing fragrance and provided significantly greater pre-rubbing and post-rubbing fragrance intensity as compared to neat fragrance in Comparative Composition S4′).
When mixing reloadable microcapsule Capsule 4 with a fragrance, the hydrophilic core solvent (i.e., triethyl citrate) can diffuse out of the reloadable microcapsule and the fragrance can diffuse into the microcapsule.
To determine the amount of the hydrophilic core solvent and fragrance that diffuse through the microcapsule wall, two microcapsule compositions S10 and S11 were prepared by mixing the following components:
S10:1.5% Model Fragrance A, 4.7% Capsule 4 slurry, and 93.8% an alcohol body spray base (95% ethanol/5% water); and
S11:1.5% Model Fragrance B, 4.7% Capsule 4 slurry, and 93.8% an alcohol body spray base (95% ethanol/5% water).
The two microcapsule compositions were allowed to sit at the room temperature for 5 days to reach the equilibrium. For each of S10 and S11, the capsules were filtered out of the base using a 1 micron glass microfiber syringe filter (Whatman). The filtrate was collected and analyzed using a gas chromatograph (GC). The % of diffused fragrance was calculated as (Initial fragrance wt %−wt % fragrance in the filtrate)/initial fragrance wt %×100%. The % of diffused triethyl citrate was calculated as
(Initial amount of triethyl citrate—the amount of triethyl citrate in the filtrate)/Initial amount of triethyl citrate×100%. S2′ described above was also analyzed as a control (data not shown in Table 8). Table 8 below provides the results for the diffusion experiment.
A melamine-formaldehyde reloadable microcapsule, i.e., Capsule 9, was prepared following the procedure described in Example 2 of U.S. Pat. No. 7,119,057. See also U.S. Pat. No. 7,196,049.
In brief, a copolymer of acrylamide and acrylic acid was first dispersed in water together with a methylated melamine-formaldehyde resin to obtain a polymer solution. A mixture of Neobee oil/triethyl citrate oil was then added into the solution with high speed shearing to form small droplets. Curing of the polymeric film over the oil droplets as capsule wall affected by increasing the solution pH to polymerize the polymers followed by heating the solution to 50 to 125° C.
Melamine-formaldehyde reloadable microcapsule thus prepared in a slurry contained in the microcapsule core by weight a mixture of 30% triethyl citrate and 70% Neobee® oil. The microcapsule core, free of an active material, constituted 32% by weight of the microcapsule slurry. Different triethyl citrate/Neobee oil weight ratio can be use, e.g., at a range of 20/80 to 50/50.
A polyurea reloadable microcapsule, i.e., Capsule 10, was prepared following the procedure below. See also U.S. Pat. No. 8,299,011 B2, Example 1.
Step 1. Preparation of the oil-in-water emulsion. One hundred twenty grams of a Neobee®/triethyl citrate oil mixture was weighed out and combined with 9.6 g of isocyanate monomer,
Lupranate® M20 (BASF corporation, Wyandotte, Mich., USA) to form the oil phase. In a separate beaker, a 3% surfactant solution (160 g) was prepared by dissolving 4.8 g of Mowet® D-425 (Akzo Nobel, Fort Worth, Tex., USA) in water. The oil phase was then emulsified into the aqueous phase to form an oil-in-water emulsion under shearing at 6500 rpm for two minutes.
Step 2. Formation of fragrance capsules. To the oil-in-water emulsion was added 10.8 g of 40% hexamethylene diamine (HMDA) (INVISTA, Wichita, Kans., USA) under agitation. The resultant capsule slurry was cured at room temperature for three hours to obtain Capsule 10.
Capsule 10 thus prepared had (i) a polyurea microcapsule wall and (ii) a microcapsule core consisting of triethyl citrate as the hydrophilic core solvent and Neobee oil as the hydrophobic core solvent. The weight ratio between triethyl citrate and Neobee oil is 30:70.
To determine the performance of Capsules 9 and 10, four microcapsule compositions (i.e., S12-15) were prepared by mixing each of the two capsules slurry obtained in the examples above with a research fragrance (i.e. Fragrance E) and a liquid detergent base (i.e., unfragranced Liquid Tide, commercially available from the Procter & Gamble Company, Cincinnati, Ohio) as follows:
S12: 0.5% fragrance E, 9.5% Capsule 9 slurry, and 90% Liquid Tide;
S13: 0.5% fragrance E, 9.5% Capsule 9 slurry containing on a solid basis 2% polyquaternium-47 (Merquat™ 2001, Lubrizol Corporation, Wickliffe, Ohio), and 90% Liquid Tide;
S14: 0.5% fragrance E, 9.5% Capsule 10 slurry, and 90% Liquid Tide; and S15: 0.5% fragrance E, 9.5% Capsule 10 slurry containing on a solid basis 1% polyquaternium-6 (Merquat™ 100, Lubrizol) and 1.5% polyvinyl amine (Lupamin® 9095, BASF), and 90% Liquid Tide.
The above compositions were aged for 4 weeks at 45° C.
A control composition, i.e., Comparative Composition S5′, was prepared by mixing 0.5% Fragrance E alone with Liquid Tide.
Each of S12-15 and S5′ (1 g) was evaluated by conducting a laundry experiment using a US wash machine. In the wash 40 grams of a sample was dosed. Terry towels were washed and then air-dried for 16 hours before being evaluated by a panel of 12 judges. The fragrance intensity was rated with an LMS scale ranging from 0 to 50. A numerical value of 5 suggests that the fabric only produce a very week intensity while a value of 30 indicates that the subject generates a strong smell, and a value of 50 indicates a very strong smell. The sensory results are shown in Table 9.
The analysis indicated that reloadable capsule compositions S12-15 provided significantly greater post-rubbing fragrance intensity as compared to neat fragrance in Comparative Composition S5′.
To determine the performance of Capsules 9 and 10 in a fabric softener, four microcapsule compositions (i.e., 516-19) were prepared by mixing each of the capsule slurries prepared in the examples above with a research fragrance (i.e. Fragrance F) and a liquid fabric softener base (i.e., unfragranced Downy, commercially available from the Procter & Gamble Company, Cincinnati, Ohio) as follows:
S16: 0.5% fragrance F, 9.5% Capsule 9 slurry, and 90% Downy;
S17: 0.5% fragrance F, 9.5% Capsule 9 slurry containing on a solid basis 2% polyquaternium-47 (Merquat™ 2001 from Lubrizol Corporation, Wickliffe, Ohio), and 90% Downy®;
S18: 0.5% fragrance F, 9.5% Capsule 10 slurry, and 90% Downy®; and
S19: 0.5% fragrance F, 9.5% Capsule 10 slurry containing on a solid basis 1% polyquaternium-6 (Merquat™ 100 from Lubrizol), 1.5% polyvinylamine (Lupamin® 9095 from BASF), and 90% Downy®.
The above compositions were aged for 4 weeks at 45° C.
A control composition, i.e., Comparative Composition S6′, was prepared by mixing 0.5% Fragrance F alone with Downy.
Each of S12-15 and S5′ (1 g) was evaluated by conducting a laundry experiment with a US washing protocol in a US wash machine. After terry towels were washed with an unfragranced Liquid Tide, 35 grams of each fabric softener (i.e., each of S16-19) was added at the rinse stage. The terry towels were air-dried for 16 hours and then evaluated by a panel of 12 judges. The fragrance intensity was rated by an LMS scale ranging from 0 to 50. A numerical value of 5 suggests that the fabric only produce very week intensity while a value of 30 indicates that the subject generates a strong smell, and a value of 50 indicates a very strong smell. The sensory results are shown in Table 10.
The analysis indicated that reloadable capsule compositions S16-19 provided significantly greater post-rubbing fragrance intensity as compared to neat fragrance in Comparative Composition S6′).
To determine the benefit of ethanol charged capsules, Capsule 4 was mixed with both ethanol and fragrance in the below ratios, creating new capsules slurries (Capsules 11 and 12) and allowed to equilibrate for 2 days before use in both fabric softener and body lotion applications. Ethanol charged Capsule 11 was prepared by mixing 30 g of capsule 4 with 30 g of ethanol and 4.8 g of Fragrance Apple and allowing the mixture to stand for 2 days before use in the application. Capsule 12 was prepared by was prepared by mixing 6.25 g of capsule 4 with 2 g of ethanol and 2.75 g of Fragrance Apple and allowing the mixture to stand for 2 days before use in the application.
To determine the performance of Capsule 11, two microcapsule compositions (i.e., S20-21) were prepared by mixing the Capsule 11 slurry into body lotion base (i.e., unfragranced Lubriderm, commercially available from the Johnson & Johnson Consumer Products Company, Skillman, N.J.) as follows: (i) S20 (uncharged): 2% Fragrance Apple, 12.5% Capsule 4 slurry, and 85.5% Lubriderm body lotion, (ii) S21 (ethanol charged): 12.5% Capsule 4 slurry, 12.5% ethanol, and 73% Lubriderm body lotion. The above compositions were aged for 3 days at room temperature.
A control composition, i.e., Comparative Composition S6′, was prepared by mixing 2% Apple Fragrance alone with 98% Lubriderm body lotion.
Each of S20-21 and S6′ (0.35 g) were applied to a blotter and evaluated after 24 by a panel of 8 judges for post rub fragrance intensity. The fragrance intensity was rated by a scale ranging from 0 to 10. A numerical value of 2 suggests that the blotter only produce very week intensity while a value of 5 indicates that the subject generates a moderately strong smell, and a value of 8 indicates a very strong smell. The sensory results are shown in Table 11.
The analysis indicated that ethanol charged reloadable capsule compositions S21 provided significantly greater post-rubbing fragrance intensity as compared to neat fragrance (Comparative Composition S6′) or the capsule without ethanol charge (Comparative Composition S20′).
To determine the performance of Capsule 12 in a fabric softener, two microcapsule compositions (i.e., S22-23) were prepared by mixing each of the capsule slurries prepared in the examples above with an Apple fragrance and a liquid fabric softener base (i.e., unfragranced Downy®, P&G) as follows:
S22: 0.423% Fragrance Apple, 1.5% Capsule 4 slurry, and 98.07% Downy®; and
S23: 4.1% Capsule 12 slurry, and 95.9% Downy®
The above compositions were aged for 4 weeks at 37° C.
A control composition, i.e., Comparative Composition S6′, was prepared by mixing 0.423% Fragrance Apple alone with Downy®.
Each of S22-23 and S6′ (40 g) was evaluated by conducting a laundry experiment with a US washing protocol. After terry towels were washed with an unfragranced Liquid Tide, 40 grams of each fabric softener (i.e., each of S22-23 and S6′) was added at the rinse stage. The terry towels were then placed in a drying cabinet at 75° F. for 4 hours and then evaluated by a panel of 7 judges. The fragrance intensity was rated by a scale ranging from 0 to 10. A numerical value of 2 suggests that the fabric only produce very week intensity while a value of 5 indicates that the subject generates a moderately strong smell, and a value of 8 indicates a very strong smell. The sensory results are shown in Table 12.
The analysis indicated that reloadable capsule compositions S23 provided significantly greater post-rubbing fragrance intensity as compared to neat fragrance (Comparative Composition S6′) or the capsule without ethanol charge (Comparative Composition S22′).
A stable capsule suspension, i.e., S24, was prepared using a visco-stable hydro-alcohol base. Specifically, 0.25 g of a crosspolymer of acrylates/C10-C30 alkyl acrylate (Ultrez® 20 from Lubrizol) was slowly added to 20.75 g of water with mixing, followed by the addition of 70 g of SD alcohol 40 (denatured alcohol) to obtain a hydro-alcohol solution. Subsequently, a slurry of Capsule 4 (5 g) was added and mixed until uniform, to which was then added 4 g of Model Fragrance C. The viscosity of the resultant mixture was adjusted with 95% Aminomethyl Propanol (AMP) (AMP-Ultra PC 2000 from Angus Chemical Company) to a viscosity of 350-500 cP. The viscosity was measured using a Brookfield® instrument with spindle #4 at a motor speed of 60 RPM. A control composition, i.e., Comparative Composition S24′, was prepared similarly except that no capsule slurry was added. Table 13 and 14 below shows the components of S24 and S24′ respectively.
Each of S24 and S24′ (0.35 g) was sprayed onto a forearm of a panelist. After 5 hours, the panelist was instructed to briefly rub the forearm and rate the fragrance intensity at a scale ranging from 0 to 100. A numerical value of 6 indicates that the composition produces a weak intensity. A value of 17 indicates a strong smell. A value of 55 designates a very strong smell.
S24 had a post-rubbing intensity of 10.4. Comparative Composition S24′ had a post-rubbing intensity of 6.9.
A reloadable microcapsule of this invention, i.e., Capsule Composition 34, was prepared following the procedure described below. More specifically, 160 g of a 50:50 mixture of NEOBEE® oil (Stepan, Chicago, Ill.; caprylic/capric triglycerides) and triethyl citrate (Citroflex® 2 from Vertellus Performance Materials, Greensboro, N.C.) was weighed out and combined with 20 g of ethylene glycol dimethacrylate (VISIOMER® EGDMA SG, Evonik CRYO LLC, Parsippany, N.J.) to form an oil phase. In a separate beaker, a 200 g aliquot of a 2% partially hydrolyzed polyvinyl alcohol solution was prepared by mixing water and polyvinyl alcohol (SELVOL™ Ultlux FA from Sekisui Specialty Chemicals America LLC, Dallas, Tex.). The oil phase was then emulsified into the 2% partially hydrolyzed polyvinyl alcohol solution to form an oil-in-water emulsion under shearing at 3000 rpm for three minutes.
The oil-in-water emulsion was placed in a round bottom vessel, sealed and purged with nitrogen gas while mixing at 350 RPM until no dissolved oxygen was detected using a dissolved oxygen meter. In a separate vessel, a solution of 3% ammonium persulfate (PeroxyChem, Philadelphia, Pa.) and 4% sodium metabisulfite (BASF CORPORATION, Florham Park, N.J.) was prepared using N2 purged water containing no dissolved oxygen as determine by a dissolved oxygen meter. A 20 g aliquot of this purged ammonium persulfate and sodium metabisulfide solution was added to the purged oil-in-water emulsion. The resultant mixture was blanketed with nitrogen, sealed and mixed for 15 minutes at 25° C. to ensure uniformity. The temperature was then raised to 65° C. and cured for 3.5 hours to obtain Capsule Composition 34. The composition was cooled to 25° C. and analyzed for free oil, particle size and performance. The average size of the capsule was measure to be in the range of 10 to 20 microns using a dynamic light scattering (DLS) instrument.
To establish the consumer benefit of reloadable microcapsules, Capsule 34 was mixed with fragrance Apple (commercially available from International Flavors & Fragrances, Union Beach, N.J.) and then added to an alcohol body spray base (95 wt % ethanol/5 wt % water) to obtain a body spray sample, i.e., S34. The sample contained by weight 1.5% fragrance, 4.7% Capsule Composition 34, and 93.8% alcohol body spray base.
A control sample, i.e., Comparative S34′, was prepared by mixing 1.5% fragrance Apple alone with the alcohol body spray base.
Each of S34 and S34′ (0.5 g) was separately sprayed onto a Lycra cloths. The cloths were allowed to dry for 24 hours. A panel of 8 judges evaluated the samples and rated the fragrance intensity both prior to rubbing (pre-rubbing) the clothes and after rubbing it (post-rubbing) 5 times. The fragrance intensity was rated at a scale ranging from 0 to 10. A numerical value of 2 indicates that the composition produces a weak intensity. A value of 10 indicates that the composition generates a very strong smell.
The sensory results are given in Table 15. The analysis indicated that reloadable capsule compositions (S34) provided significantly greater pre-rubbing and post-rubbing fragrance intensity as compared to neat fragrance in Comparative Composition S34′.
A reloadable microcapsule of this invention, i.e., Capsule Composition 36, was prepared following the procedure described below. Specifically, 232.5 g of a 50:50 mixture of NEOBEE® oil (Stepan, Chicago, Ill.; a mixture of caprylic/capric triglycerides) and triethyl citrate (Citroflex® 2 from Vertellus Performance Materials, Greensboro, N.C.) was weighed out to form an oil phase. In a separate beaker, a 135 g of a 1% cetyl trimethyl ammonium chloride (Sigma Aldrich, Saint Louis, Mo.) was prepared using water. The oil phase was then emulsified into the surfactant solution to form an oil-in-water emulsion under shearing at 15000 rpm for three minutes.
The oil-in-water emulsion was placed in a round bottom vessel and mixed at 350 RPM. The pH of the mixture was evaluated and adjusted to 3.8. Water was added to the vessel bringing a total sample weight to 559.74 g. A 40.26 g aliquot of Tetraethyl orthosilicate (Dynasylan® TEOS UHP, Evonik Degussa Corporation, Parsippany, N.J.) was then added to the mixture while mixing. The resultant mixture was agitated at 350 RPM for 48 hours at 25° C. to obtain Capsule Composition 36.
Capsule Composition 36 was mixed with a model fragrance having a high vapor pressure and then added to an alcohol body pray base (95 wt % ethanol/5 wt % water) to obtain a body spray sample, i.e., S37. The sample contained by weight 4% fragrance, 16% Capsule Composition 36 and 80% alcohol body spray base.
A control sample, i.e., Comparative S36′, was prepared by mixing 4% of the model fragrance with the alcohol body spray base.
Each of S36 and S36′ (0.5 g) was sprayed onto a Lycra cloths. The cloths were allowed to dry for 24 hours. A panel of 6 judges evaluated the samples and rated the fragrance intensity both prior to rubbing (pre-rubbing) the clothes and after rubbing it (post-rubbing) 5 times. The fragrance intensity was rated at a scale ranging from 0 to 10. A numerical value of 2 indicates that the composition produces a weak intensity. A value of 10 indicates that the composition generates a very strong smell.
The sensory results are given in Table 16. The analysis indicated that reloadable capsule compositions (S36) provided significantly greater pre-rubbing and post-rubbing fragrance intensity as compared to neat fragrance in Comparative S36′.
Capsule Composition C38 of this invention was prepared following the procedure below. NEOBEE® oil (120 g, the hydrophobic solvent) and triethyl citrate (Citroflex® 2 Vertellus Performance materials, Greensboro, N.C.) (120 g, the hydrophilic solvent) were combined with 4.8 g of isocyanate monomer, LUPRANATE® M20 to form an oil phase. In a separate beaker, a 0.5% surfactant solution (319.2 g) was prepared by dissolving 1.6 g of Mowiol® 3-85, a partially hydrolyzed polyvinyl alcohol (Kuraray, Houston, Tex.) in water. The oil phase was then emulsified into the surfactant solution to form an oil-in-water emulsion under shearing at 3000 rpm for three minutes. To the oil-in-water emulsion was added 36 g of 6% HMDA aqueous solution under agitation. The capsule slurry was cured at 55° C. for three hours to obtain Capsule Composition C38. The average particle size of the capsule was measure to be 30 microns using a DLS instrument.
Two 100 g insect repellent samples were prepared each containing a commercial DEET product (SCJ OFF Family care containing 7% DEET). Sample S38-1 was dosed with 10% of Capsule Composition C38. Sample S38-2 was dosed with 20% of Capsule Composition C38. Each sample was separately added to a pump spray bottle and allowed to equilibrate for 3 days. The samples were evaluated for their ability to repel mosquitoes in blood well tests. The commercial DEET product without capsules was used as a control sample (S38′). The results were shown in Table 17 below. Samples S38-1 and S38-2 showed significant improvement over the control sample in mosquito repellency.
Capsule Composition 40 of this invention was prepared following the procedure below. Gelatin capsules (diameter˜30-50 microns) were prepared by first dissolving 4 g of gelatin 225 bloom into 200 g of hot water. Gelatin was stirred using a top down stirrer at 400 RPM for 20 min. Water was maintained at temperatures between 50-65° C. to allow the gelatin to become fully hydrated. While mixing, 21.5 g of (wt/wt) solution of gum Arabic Senegal followed by addition of 50 g of a 50:50 mixture of NEOBEE® oil (Stepan, Chicago, Ill.; a mixture of caprylic/capric triglycerides) and triethyl citrate (Citroflex® 2 Vertellus Performance materials, Greensboro, N.C.). The resultant solution was homogenized at 6500 RPM using a homogenizer for 1 minute. The resultant mixture was stirred at 400 RPM for 5 minutes, adjusted to pH 3.1-3.25, and heated to 50° C. under agitation for 1 to 2 hours to obtain Capsule Composition 40. Capsules could also be placed through a cross-linking post treatment of giving a more robust capsule using transglutaminase, gluteraldehyde or other cross-linkers known in the art for gelatin capsule preparation.
A silica/gelatin microcapsule of this invention, i.e., Capsule Composition 41, was prepared following the procedure. Tetraethyl orthosilicate (TEOS) (commercially available from Evonik Corporation, Piscataway, N.J.) 40 g was added to 36 g 0.01 N hydrochloric acid and the mixture was stirred at 45° C. for 30 minutes. Additional 376 g TEOS was added dropwise during 1 hour. The mixture was stirred at 45° C. overnight, and loaded into a Rotavapor to remove lights with the aid of 10 mmHg vacuum. The resulting 275 g colorless liquid polysiloxane material (Poly-Si®) was saved and used in capsule preparation. The polysiloxane materials thus prepared have a viscosity of 5-30 (Brookfield® DV1 viscometer, 60 rpm, ambient temperature, spindle 4), and a molecular weight of between 1000 and 3000.
A solution of 2 g gelatin A (commercially available from Great Lakes Gelatin Co., Grayslake, Ill.) in 118 g of water was heated to 50° C. Gum Arabic (2 g) was added as a 10% aqueous solution (20 g), followed by the addition of 40 g of a 50:50 mixture of NEOBEE® oil (Stepan, Chicago, Ill.; a mixture of caprylic/capric triglycerides) and triethyl citrate (Citroflex® 2 Vertellus Performance materials, Greensboro, N.C.) in 10 g of pretreated silica Poly-Si. The pH was adjusted to 4.5 with 10% acetic acid solution. The resultant mixture was stirred with an overhead stirrer at 600 rpm and cooled slowly to room temperature (20° C.). Consequently, to the mixture was added a solution of 6 g of sodium silicate (37.5% aqueous solution, commercially available from PQ Corp., Malvern, Pa.) in 80 g of water. After the pH was adjusted to 6.6, the resultant mixture was stirred for 1 hour at room temperature to obtain Capsule 5. The amount of precursor (e.g., pretreated silica Poly-Si as used in this example) was routinely determined by the wall polymer level needed and was generally 5% to 50% of the final formulation. A skilled person in the art would be able to adjust the precursor amount, without undue experimentation, to prepare microcapsules having a desirable wall thickness and release profile.
A polyurea/silica hybrid microcapsule composition of this invention, i.e., Capsules Composition 42, was prepared following the procedure. 240 g of a 50:50 mixture of caprylic/capric triglycerides (NEOBEE® oil, Stepan, Chicago, Ill.) and triethyl citrate (Citroflex® 2 Vertellus Performance materials,
Greensboro, N.C.) was mixed in a beaker, 12 g of tetraethyl orthosilicate (commercially available from Evonik, Essen, Germany), and 19.2 g of Lupranate® M20 (a polymeric methylene diphenyl diisocyante-based resin containing multiple isocyanate groups, commercially available from BASF, Wyandotte, Mich.), to form an oil phase. In a separate beaker, an aqueous solution of 319.2 g of 0.9% Mowiol® 4-98 (a fully hydrolyzed polyvinyl alcohol, commercially available from Kurary America Inc., Houston, Tex.) and 0.9% Walocel® CRT 50000 PA (sodium carboxymethylcellulose; a co-dispesant commercially available from Dow, Midland, Mich.) was prepared and then emulsified with the oil phase to form the fragrance emulsion under high shearing at 9500 rpm for three minutes. After the fragrance emulsion was heated to 35° C., 4.3 g of hexamethylene diamine (“HMDA,” 40% in water, commercially available from Sigma-Aldrich, St. Louis, Mo.) and 5.2 g of water was added under constant mixing with an overhead mixer. After 15 minutes of stirring at 35° C., the capsule slurry was cured at 55° C. for two hours and then cooled to room temperature.
A polyurea/silica hybrid microcapsule composition, i.e., Capsule Composition 43, can be prepared following the procedure. An aqueous phase is provided by mixing 30 g of 10% a copolymer of vinyl Amine/vinyl alcohol (Selvol® Ultalux AD, Sekisui Specialty Chemicals, Secaucus, N.J.), 100 g of 3% polyquaternium-10 (UCARE™® Polymer JR-30M, Dow, Midland, Mich.), 3 g of an aminoethylaminopropyl polysiloxane (Silamine® 2972, Siltech, Toronto, Canada) and 160.8 g of water. In a separate container, an oil phase is provided by mixing 240 g of a 50:50 mixture of caprylic/capric triglycerides (NEOBEE® oil, Stepan, Chicago, Ill.) and triethyl citrate (Citroflex® 2, Vertellus Performance Materials, Greensboro, N.C.), 12.08 g of tetraorthosilicate (Evonik) and 11.52 g of a xylylene diisocyanate adduct 25 polymer (Takenate® D110-N, Mitsui Chemicals). The oil phase is then emulsified into the aqueous phase under a shearing rate of 3000 to 150000 rpm (e.g., 8000 rpm) for three minutes to form an oil-in-water fragrance emulsion. The fragrance emulsion is then heated to 35° C., followed by addition of 5.04 g of branched polyethylenimine (BASF) and 37.56 g of water under agitation for 5 minutes. The resultant slurry is cured at 55° C. for two hours to obtain Capsule Composition 43.
Capsule Composition 44 of this invention has a primary alcohol in its core for increased diffusivity of fragrance entering the core. An oil phase is provided by mixing NEOBEE® oil (117.6 g), triethyl citrate (Citroflex® 2, Vertellus Performance Materials, Greensboro, N.C.) (117.6 g), 4.8 g of geraniol, and 4.8 g of isocyanate monomer, LUPRANATE® M20. A 0.5% surfactant solution (319.2 g) is prepared by dissolving 1.6 g of Mowiol® 3-85, a partially hydrolyzed polyvinyl alcohol (Kuraray, Houston, Tex.) in water. The oil phase is then emulsified into the surfactant solution to form an oil-in-water emulsion under shearing at 3000 rpm for three minutes. The oil-in-water emulsion is added 36 g of 6% HMDA aqueous solution. The resultant slurry is cured at 55° C. for three hours to obtain Capsule Composition 44 with an average particle size of 25-35.
Capsule Composition 45 of this invention has a primary alcohol in its core for increased diffusivity. An oil phase is provided by mixing NEOBEE® oil (114 g) and triethyl citrate (Citroflex® 2, Vertellus Performance materials, Greensboro, N.C.) (114 g), 12 g of geraniol, and 19.2 g of isocyanate monomer (LUPRANATE® M20). A 0.5% surfactant solution (319.2 g) is prepared by dissolving 1.6 g of Mowiol® 3-85, a partially hydrolyzed polyvinyl alcohol (Kuraray, Houston, Tex.) in water. The oil phase is then emulsified into the surfactant solution to form an oil-in-water emulsion under shearing at 3000 rpm for three minutes. The oil-in-water emulsion is added 21.6 g of 40% HMDA aqueous solution under agitation. The resultant slurry is cured at 55° C. for three hours to obtain Capsule Composition 45 with a particle size of 5-15.
A perfume spray product, S46-1, was prepared by mixing the following ingredients:
Water: 13%
Ethanol: 70%
Fragrance: 12%
Capsule Composition C38: 5%
A perfume spray product, S46-2, was prepared by mixing the following ingredients:
Fragrance: 12%
Water: 12.2%
Polyacrylate Crosspolymer-6: 0.8%
Ethanol: 70%
Capsule Composition C38: 5%
A control S46′ was prepared by mixing the following ingredients:
Water: 8%
Ethanol: 80%
Fragrance: 12%
The perfume spray products S46-1, S46-2, and S46′ were sprayed onto a forearm of a panelist. At time 0 and after 6 hours, the forearm was measure for the headspace concentration of the fragrance. The results are shown in Table 18 below.
Capsule Composition C47 of this invention was prepared following the procedure below. An oil phase was prepared by mixing 126 g of NEOBEE® oil, 48 g of DEET (Sigma Aldrich, St. Louis, Mo.), 9.504 g of LUPRANATE® M20 (isocyanate monomer). In a separate beaker, a surfactant solution was prepared by mixing 241.8 g of water, 29.7 g of a 10% solution of PVP K90 (polyvinylpyrrolidone having a weight average molecular weight of 360,000, commercially available from Ashland, Covington, Ky.), and 59.4 g of a 20% solution of Luviquat® PQ-11 (polyquaternium-11 commercially available from BASF, Florham Park, N.J.). The oil phase was then emulsified into the surfactant solution to form an oil-in-water emulsion under shearing at 12500 rpm for three minutes. After heating the oil-in-water emulsion to 35° C., a 26.136 g of 16.36% HMDA aqueous solution was added under agitation. The resultant mixture was heated to 55° C., cured for 2 hours, and then cooled to 25° C., followed by the addition of 6 g of Aculyn 33A (an alkali-swellable anionic acrylic polymer emulsion) as a Rheology modifier to obtain Capsule Composition C47.
An absorbing capsule was prepared using the procedure similar to that described in Example 4 above.
More specifically, an aqueous phase was prepared by adding 0.47 g of polyvinyl alcohol (commercially available under the trade name of Selvol™ Ultalux FP, Sekisui Specialty Chemicals, Dallas, Tex.) to 41 g of water. An oil phase was prepared by mixing 20 g of triethyl citrate and 20 g of a caprylic/capric triglyceride (Neobee® oil, Stepan Company, Chicago, Ill.). The oil phase was emulsified into the aqueous phase to obtain an oil-in-water emulsion. A polyisocyanate (20 g in 20 g of water) was then added to the oil-in-water emulsion and mixed well. Subsequently, polymeric methylene diphenyl diisocyanate (0.5 g, Lupranate® M20, BASF, Florham Park, N.J.) was added followed by the addition of 0.51 g of HMDA. The reaction mixture was heated to 55° C. and maintained at that temperature for 2 hours and then cooled to 25° C. to obtain a slurry, to which an emollient mixture was adding containing 1.25 g of a blend of caprylyl glycol and pentylene glycol (Microcare® Emollient CPG, Thor Personal Care SAS, France) and 0.5 g of benzyl alcohol (Microcare® BNA, Thor), together with the addition of 0.5 g of a crosslinked polyacrylic acid polymer (Carbopol® 981, Lubrizol, Wickliffe, Ohio). The absorbing capsule slurry was mixed well. The absorbing microcapsule thus prepared had particle size of 30-60 microns in diameter.
Eau de toilette samples, e.g., Examples 48-54, were prepared using the absorbing microcapsule, Model Fragrance A, a hydrocolloid, a neutralizing agent, ethanol, and water. The wt % of each component is shown in Table 19 below. The hydrocolloid was selected from the group consisting of a hydrophobically modified crosspolymer of acrylates and C10-C30 alkyl acrylate (commercially available under the trade name of Carbopol® Ultrez 20, Lubrizol, Wickliffe, Ohio), a crosslinked homopolymer of acrylic acid (commercially available under the trade name of Carbopol® Ultrez 30, Lubrizol, Wickliffe, Ohio), and a cross-linked copolymer of vinyl pyrrolidone and acrylic acid (commercially available under the trade name of Ultrathix™ P-100, Ashland Specialty Chemical, Covington, Ky.). The neutralizing agent is selected from the group consisting of tetrahydroxypropyl ethylene diamine (commercially available under the trade name of Neutrol® TE, BASF, Florham Park, N.J.), 2-amino-2-methyl-1-propanol (AMP, Dow Chemical, Midland, Mich.), octadecyldimethylamine (commercially available under the trade name of Armeen® DM18D, Akzo Nobel, Fort Worth, Tex.), and bis(2-hydroxylethyl)soyaalkylamine (commercially available under the trademark of Ethomeen® SV/12 from Nouryon, Bridgewater, N.J.).
A silica microcapsule was prepared using a procedure described in U.S. Pat. No. 9,532,933 B2.
Eau de toilette samples, e.g., Examples 55-59, were prepared using the silica microcapsule, Model Fragrance B (Example 55), Model Fragrance C (Examples 56 and 57), Model Fragrance D (Examples 58 and 59), a hydrocolloid, a neutralizing agent, ethanol, and water. The wt % of each component is shown in Table 19 below.
Examples 48 and 49 were stable for at least 28 days at room temperature.
Examples 50-52 were stable for at least 14 days at 40° C.
Example 50 had a pH of 7.7. Example 51 had a pH of 7.34. Example 52 had a pH of 6.43.
Examples 50-59 each had a viscosity suitable for spraying applications.
Examples 53 and 54 were stable for a min of 3 freeze-thaw cycles.
Examples 54 and 56 were measured for the CIE L*a*b* color scale where L=100 is full transmission, a* axis represents the green-red component, with green in the negative direction and red in the positive direction, and the b* axis represents the blue-yellow component, with blue in the negative direction and yellow in the positive direction. Example 54 has a lightness value L=70.47 and Example 56 has a lightness value L=93.79.
All of the features disclosed in this specification may be combined in any combination. Each feature disclosed in this specification may be replaced by an alternative feature serving the same, equivalent, or similar purpose. Thus, unless expressly stated otherwise, each feature disclosed is only an example of a generic series of equivalent or similar features.
Indeed, to achieve the purpose of preparing a reloadable microcapsule and a composition containing the reloadable microcapsule, one skilled in the art can choose different wall-forming materials/encapsulating polymers, hydrophilic core solvents, hydrophobic core solvents, external hydrophilic solvents, active materials, and/or capsule formation aids/catalysts, varying the concentrations of these wall-forming materials and/or catalysts to achieve desirable thickness of the wall/diffusion rate/organoleptic or release profiles in a consumer product. Further, the ratios among their wall-forming materials, capsule forming aids, adjuvants, core modifiers, active materials, and catalysts can also be determined by a skilled artisan without undue experimentation.
From the above description, a skilled artisan can easily ascertain the essential characteristics of the present invention.
This application is a continuation-in-part of U.S. application Ser. No. 15/808,845 filed Nov. 9, 2017, which claims the benefit of International Application No. PCT/US2017/030729, filed May 3, 2017, which in turn claims priority to U.S. Application Ser. No. 62/331,230, filed May 3, 2016. The contents of all applications are incorporated by reference in their entirety.
| Number | Date | Country | |
|---|---|---|---|
| 62331230 | May 2016 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15808845 | Nov 2017 | US |
| Child | 16284605 | US | |
| Parent | PCT/US2017/030729 | May 2017 | US |
| Child | 15808845 | US |
